{"meta":{"query_hash":"277401410e68","filters":{"venue":"American Journal of Cardiovascular Drugs"},"cohort_total":64,"direct_labels_cover":0,"predictions_cover":64,"exported":64,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/277401410e68","api":"https://metacan.xera.ac/api/v1/cohort?venue=American+Journal+of+Cardiovascular+Drugs"},"results":[{"id":"W1003900968","doi":"10.2165/00129784-200606060-00006","title":"Bedtime Administration of Graded-Release Diltiazem in Patients with Inadequate BP Control","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Delta-Q Technologies (Canada); Canadian Heart Research Centre","funders":"","keywords":"Diltiazem; Bedtime; Medicine; Adverse effect; Ambulatory; Internal medicine; Anesthesia","score_opus":0.0037201546301360595,"score_gpt":0.19482486444820446,"score_spread":0.1911047098180684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1003900968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214804,0.006294339,0.0005320947,0.00039866182,0.00005016684,0.00021360611,0.0000067379206,0.000006955149,0.00034941552],"genre_scores_gemma":[0.998742,0.00008214927,0.00063093175,0.00037035267,0.0001320542,0.0000031374782,0.000005266537,0.00001866987,0.000015449645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981877,0.00014368798,0.0005408667,0.00014045964,0.0008041604,0.0001831098],"domain_scores_gemma":[0.99859923,0.000061123406,0.00040193912,0.0002621634,0.0005811399,0.00009441784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039951122,0.00015271167,0.0012418529,0.0001929731,0.000028251969,0.0000075415246,0.00007525709,0.000032130407,0.000005079128],"category_scores_gemma":[0.000031496493,0.000107772255,0.00048207372,0.0003303197,0.00021338092,0.00009861338,0.00001241706,0.00021120945,0.000001678698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018817471,0.0039449777,0.58998173,0.0003601381,0.038831454,0.0017757105,0.0016133621,0.0051518786,0.0005569179,0.00020830077,0.0046304357,0.3341276],"study_design_scores_gemma":[0.02610756,0.0060098907,0.9302513,0.00054653804,0.011285779,0.00036023004,0.001022132,0.000038564645,0.0016007413,0.00006842368,0.02232109,0.00038774373],"about_ca_topic_score_codex":0.0002697889,"about_ca_topic_score_gemma":0.000005173876,"teacher_disagreement_score":0.34026957,"about_ca_system_score_codex":0.000019370898,"about_ca_system_score_gemma":0.00013819113,"threshold_uncertainty_score":0.4394825},"labels":[],"label_agreement":null},{"id":"W124523853","doi":"10.2165/00129784-200101040-00003","title":"Patient Self-Monitoring of Oral Anticoagulant Therapy","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Warfarin; Atrial fibrillation; Intensive care medicine; Anticoagulant; Pharmacotherapy; Self-monitoring; Dosing; Anticoagulant therapy; Surgery; Internal medicine","score_opus":0.061679759266556104,"score_gpt":0.35139503303642033,"score_spread":0.2897152737698642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W124523853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022034694,0.99607843,0.00017642773,0.000041396634,0.00065046834,0.0005050569,0.0000022208762,0.000021006108,0.00032152937],"genre_scores_gemma":[0.0018129746,0.9940349,0.0026554144,0.000013829567,0.0013794582,0.0000015028692,0.000004939658,0.00006495736,0.00003200914],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664366,0.00037726478,0.0013170759,0.00021324563,0.0011948207,0.0002539483],"domain_scores_gemma":[0.9971702,0.00012002031,0.0016503779,0.00056216365,0.00033182488,0.00016540437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009177418,0.00036995174,0.004961701,0.000513172,0.000035712303,0.00002008391,0.00018785083,0.00008629143,0.000016262988],"category_scores_gemma":[0.000054265874,0.00025102493,0.0068141297,0.0008202448,0.000105428495,0.000082516,0.000052406933,0.0003380487,0.0000083498235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045496454,0.00001860599,0.0010827571,0.0010726859,0.016480515,0.00014023735,0.00016376069,0.000026987325,2.8023842e-7,0.000003957016,0.00004764756,0.9809171],"study_design_scores_gemma":[0.00090501946,0.0006542425,0.0002478448,0.0041215206,0.009841365,0.000505091,0.00032153522,8.1684925e-7,0.000008147974,0.0000019217778,0.98317975,0.00021272253],"about_ca_topic_score_codex":0.000024954279,"about_ca_topic_score_gemma":1.7058229e-8,"teacher_disagreement_score":0.9831321,"about_ca_system_score_codex":0.00013702868,"about_ca_system_score_gemma":0.00027595472,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W161538956","doi":"10.2165/00129784-200707040-00005","title":"Impact of Weight-Loss Medications on the Cardiovascular System","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Weight loss; Overweight; Obesity; Risk factor; Pharmacotherapy; Intensive care medicine; Diabetes mellitus; Adverse effect; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.027601850045885574,"score_gpt":0.35034674951505157,"score_spread":0.322744899469166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W161538956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017145692,0.9949905,0.0005240531,0.00006518878,0.0004155379,0.0008684548,0.000037183534,0.000022871985,0.0013616271],"genre_scores_gemma":[0.02544917,0.97323704,0.00014772521,0.00004574909,0.00096081727,0.000035359404,0.000017637127,0.000078726946,0.00002777212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994347,0.0014466211,0.001439949,0.00037244093,0.001936498,0.00045753882],"domain_scores_gemma":[0.9951121,0.00072493136,0.0014650659,0.0016771386,0.0005925656,0.0004281859],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0044932193,0.0006179635,0.006799806,0.00065978535,0.00013216826,0.0000097837055,0.00062001136,0.00023478051,0.00004008271],"category_scores_gemma":[0.00011244202,0.0003193935,0.024447417,0.0010440553,0.00073790585,0.000053359323,0.000065820845,0.0012626431,0.00005404432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076257675,0.00021812336,0.00005046292,0.0023793923,0.19398652,0.00096013333,0.00014523488,0.0000990526,1.5526744e-7,0.000053685326,0.0004856832,0.8015453],"study_design_scores_gemma":[0.0012303136,0.0010772342,0.00028868,0.009440938,0.095314436,0.0073291953,0.0001592636,0.0000014592646,0.000010657698,0.0000021948943,0.88488543,0.00026018577],"about_ca_topic_score_codex":0.000098707445,"about_ca_topic_score_gemma":1.12167704e-7,"teacher_disagreement_score":0.8843998,"about_ca_system_score_codex":0.0011034118,"about_ca_system_score_gemma":0.001614814,"threshold_uncertainty_score":0.9999258},"labels":[],"label_agreement":null},{"id":"W163982164","doi":"10.2165/00129784-200707060-00007","title":"Estimating the Cost Effectiveness of Ramipril used for Specific Clinical Indications","year":2007,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ramipril; Quality-adjusted life year; Life expectancy; Cost effectiveness; Clinical trial; Pharmacoeconomics; Intensive care medicine; Quality of life (healthcare); Internal medicine; Population; Environmental health; Risk analysis (engineering)","score_opus":0.20986678129403516,"score_gpt":0.4450840668693218,"score_spread":0.23521728557528662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W163982164","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39919412,0.0038984944,0.59403974,0.00101152,0.0008340863,0.00070742326,0.000041225092,0.000007573175,0.0002657899],"genre_scores_gemma":[0.9742197,0.0001522511,0.024339002,0.00042313623,0.0007943145,0.000027262622,0.0000057147354,0.000032103046,0.000006534634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99325746,0.0011489723,0.004768629,0.00028148876,0.00023569466,0.00030774818],"domain_scores_gemma":[0.98566616,0.008120596,0.005063091,0.00067177933,0.0003082231,0.00017016423],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.122330666,0.00014828338,0.0018392251,0.00029837483,0.00016161203,0.000036651898,0.00047348425,0.0000690146,0.000013065993],"category_scores_gemma":[0.0043913545,0.00013999162,0.0015062575,0.0003891191,0.00043807435,0.00021357175,0.00003333664,0.00028484652,0.000038505783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001089992,0.0012451299,0.3195509,0.0018966586,0.025021905,0.000017948865,0.01675258,0.09050342,0.00004990611,0.09099678,0.0065064766,0.4463683],"study_design_scores_gemma":[0.012168864,0.001824686,0.6182308,0.0010276976,0.0008035267,0.00022474461,0.013966561,0.0076299543,0.0003233416,0.014726429,0.32778865,0.001284722],"about_ca_topic_score_codex":0.00010668973,"about_ca_topic_score_gemma":0.000001938004,"teacher_disagreement_score":0.57502556,"about_ca_system_score_codex":0.00027796233,"about_ca_system_score_gemma":0.00020914941,"threshold_uncertainty_score":0.9037453},"labels":[],"label_agreement":null},{"id":"W167127537","doi":"10.1007/bf03256594","title":"Extended Dalteparin Prophylaxis for Venous Thromboembolic Events","year":2009,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Royal Jubilee Hospital; Toronto East General Hospital; Sunnybrook Health Science Centre; Augmentium Pharma Consulting (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Warfarin; Pulmonary embolism; Arthroplasty; Knee replacement; Venous thrombosis; Orthopedic surgery; Deep vein; Hip fracture; Hip replacement; Thrombosis; Surgery; Anesthesia; Internal medicine; Atrial fibrillation","score_opus":0.008735250268885322,"score_gpt":0.266173251892355,"score_spread":0.2574380016234697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167127537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97980124,0.0072292206,0.007892717,0.0010990036,0.00047726338,0.0011836505,0.000005925246,0.00004781668,0.002263176],"genre_scores_gemma":[0.99201643,0.0017652512,0.0044747153,0.0009194897,0.0007130995,0.00002219681,0.0000054133247,0.00004177103,0.0000416537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755657,0.00012376191,0.0006293367,0.00029690462,0.00092853257,0.00046490526],"domain_scores_gemma":[0.9981624,0.00003994447,0.00042794592,0.0006397332,0.00043091874,0.00029906607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011112149,0.00026135342,0.0018804241,0.0002779986,0.000118097996,0.000025749581,0.00022013436,0.000053005308,0.000013982373],"category_scores_gemma":[0.00011867646,0.00021453253,0.0021160825,0.0003953069,0.000114013084,0.00013376781,0.00003251534,0.00026158508,0.000011814449],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002986486,0.0018215101,0.00016591695,0.00009278076,0.0060968576,0.00023652679,0.0010627375,0.000490986,0.00033580686,0.0003761099,0.0018059069,0.98721623],"study_design_scores_gemma":[0.014686796,0.053909075,0.5380393,0.0009438741,0.01544466,0.0035117946,0.0039683417,0.00012967152,0.0038318306,0.004094467,0.36006096,0.0013791852],"about_ca_topic_score_codex":0.000044147007,"about_ca_topic_score_gemma":3.5335052e-7,"teacher_disagreement_score":0.98583704,"about_ca_system_score_codex":0.00016236112,"about_ca_system_score_gemma":0.00019997336,"threshold_uncertainty_score":0.8748383},"labels":[],"label_agreement":null},{"id":"W172350394","doi":"10.2165/11533430-000000000-00000","title":"Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"Merck; AstraZeneca","keywords":"Rosuvastatin; Simvastatin; Fenofibrate; Medicine; Rosuvastatin Calcium; Pharmacology; Statin; Combination therapy; Internal medicine","score_opus":0.005283008122858314,"score_gpt":0.22650469904548856,"score_spread":0.22122169092263025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172350394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945291,0.0043776785,0.0002836161,0.00014655551,0.00007225133,0.0005386596,0.0000061942087,0.0000072379107,0.000038667033],"genre_scores_gemma":[0.9925577,0.0041708373,0.0030592305,0.00008968526,0.00007161802,0.0000054176808,0.000004878945,0.000038854207,0.0000017830678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99798137,0.00024847206,0.00052815094,0.0002668029,0.00074654416,0.00022863681],"domain_scores_gemma":[0.99860847,0.00015962833,0.00034357057,0.00037448385,0.0002840945,0.00022974522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013343364,0.00022413723,0.0011463793,0.00024312228,0.000054654858,0.000023793707,0.00007041093,0.000066223234,0.000002808126],"category_scores_gemma":[0.0000962099,0.00016438427,0.00024912372,0.0003218289,0.00040211654,0.00017050454,0.000025690351,0.00044377075,1.6341842e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010029457,0.00015548366,0.083325945,0.000058639143,0.0016782159,0.00001812215,0.001228483,0.000044772485,0.0008888923,0.000013957367,0.0000025149534,0.9025555],"study_design_scores_gemma":[0.051279973,0.0044553475,0.939972,0.00016386107,0.00037874153,0.00018714381,0.0005590365,0.000027273296,0.00081142935,0.000010559595,0.0019502915,0.00020434207],"about_ca_topic_score_codex":0.0001640315,"about_ca_topic_score_gemma":0.000005437517,"teacher_disagreement_score":0.9023512,"about_ca_system_score_codex":0.00004194969,"about_ca_system_score_gemma":0.00013480952,"threshold_uncertainty_score":0.6703396},"labels":[],"label_agreement":null},{"id":"W18416084","doi":"10.2165/00129784-200202050-00005","title":"Prevention of Restenosis with Antioxidants","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Pharmacotherapy; Restenosis; Intensive care medicine; Pharmacology; Internal medicine; Stent","score_opus":0.03257317113756302,"score_gpt":0.3075143393641712,"score_spread":0.2749411682266082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W18416084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021315715,0.9944588,0.0017212527,0.00001637944,0.00009711355,0.00045742933,0.00001616125,0.000011174309,0.0010901461],"genre_scores_gemma":[0.0053827334,0.9922914,0.0017340485,0.000008272543,0.00030774513,0.0000069339912,0.00000864818,0.00007586259,0.00018433969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963693,0.00066076615,0.0010844842,0.00030942087,0.001294396,0.00028164577],"domain_scores_gemma":[0.99599487,0.00015009483,0.0024042865,0.00068292813,0.0005715227,0.00019631926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008728157,0.0004376417,0.0057407487,0.000594745,0.000044869128,0.00001578004,0.00026759063,0.00013088272,0.000035172765],"category_scores_gemma":[0.00009013701,0.00029272508,0.0052208784,0.0009849633,0.0005488336,0.00019268318,0.000044012275,0.0007122716,0.000009050606],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009627223,0.00020281224,0.000039580314,0.0048518176,0.01558197,0.00024563656,0.000105604464,0.0000079844085,0.0000013965903,0.0000062481176,0.00007244201,0.97878826],"study_design_scores_gemma":[0.0013093109,0.0025561103,0.00024271764,0.05065188,0.031450342,0.0041330103,0.0004288895,9.922323e-7,0.000059195245,0.000003991045,0.90878576,0.000377805],"about_ca_topic_score_codex":0.000025490945,"about_ca_topic_score_gemma":4.2331382e-7,"teacher_disagreement_score":0.9784104,"about_ca_system_score_codex":0.000112336165,"about_ca_system_score_gemma":0.0004332428,"threshold_uncertainty_score":0.9999525},"labels":[],"label_agreement":null},{"id":"W19483797","doi":"10.2165/00129784-200303001-00004","title":"A Metabolic Approach to the Management of Ischemic Heart Disease","year":2003,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Disease management; Cardiology; Disease; Internal medicine","score_opus":0.007764721654874047,"score_gpt":0.22599666288315945,"score_spread":0.2182319412282854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19483797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83337694,0.07307436,0.06380171,0.0019556184,0.0010484662,0.0014661175,0.000011598185,0.000047012552,0.02521816],"genre_scores_gemma":[0.9908215,0.0018577352,0.005980183,0.0009082506,0.00019378381,0.000014891115,0.0000018531493,0.000034831977,0.00018698626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974883,0.00031071558,0.000468096,0.00022111295,0.0012620459,0.00024970583],"domain_scores_gemma":[0.9981695,0.000024147159,0.00018271159,0.00092036446,0.000278977,0.00042430943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016825256,0.0001915651,0.0010450099,0.00020299593,0.000059200775,0.000014840837,0.00017684206,0.000020029276,0.000015438925],"category_scores_gemma":[0.000059398262,0.00011847663,0.003398006,0.000839375,0.00017073298,0.000056632372,0.00003698519,0.00025061448,0.000016255002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033137326,0.0022851634,0.024439428,0.001137066,0.21837579,0.00065400574,0.0065503474,0.05863847,0.0007871748,0.0034055728,0.051388483,0.62902474],"study_design_scores_gemma":[0.0014197839,0.00012248315,0.022341244,0.00008664915,0.006489613,0.00071379606,0.0035407087,0.000008391636,0.00074698403,0.000006117814,0.9643748,0.00014945114],"about_ca_topic_score_codex":0.000027520937,"about_ca_topic_score_gemma":3.5660392e-8,"teacher_disagreement_score":0.9129863,"about_ca_system_score_codex":0.000047651225,"about_ca_system_score_gemma":0.00013722248,"threshold_uncertainty_score":0.48313367},"labels":[],"label_agreement":null},{"id":"W1970093780","doi":"10.2165/00129784-200404050-00002","title":"Interactions Between Grapefruit Juice and Cardiovascular Drugs","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":239,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"","keywords":"Grapefruit juice; Pharmacology; Bioavailability; Felodipine; Medicine; Fluvastatin; Nisoldipine; Repaglinide; Nitrendipine; Verapamil; Oral administration; Cisapride; Pharmacokinetics; Chemistry; Nifedipine; Metformin; Endocrinology; Internal medicine; Simvastatin; Insulin; Calcium","score_opus":0.08993227723574834,"score_gpt":0.42836363717711545,"score_spread":0.3384313599413671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970093780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005969114,0.99281174,0.00067316735,0.000068654015,0.0031974753,0.0007618366,0.00016172971,0.000051699146,0.0016767797],"genre_scores_gemma":[0.0042645754,0.9914216,0.00062394276,0.00019693002,0.0030730108,0.000059194786,0.000037684546,0.00020631617,0.00011679443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913803,0.003427236,0.0020688716,0.0008635446,0.0013095504,0.0009505361],"domain_scores_gemma":[0.99481106,0.00085747126,0.0015905435,0.0010930297,0.0005414247,0.0011064953],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00491992,0.0011478055,0.0074255797,0.001022551,0.00036789704,0.000110379515,0.0011762847,0.0004781983,0.0001182746],"category_scores_gemma":[0.00012750873,0.000999247,0.011393434,0.0012224928,0.0009946333,0.0002847546,0.00035452616,0.0039136466,0.000101964375],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028763361,0.000085548534,0.00000995079,0.0018710534,0.059921652,0.00021555476,0.0006952396,0.00059932686,0.0000012173095,0.0000311062,0.00030634872,0.93623424],"study_design_scores_gemma":[0.0016740586,0.00013414616,0.000009428446,0.0018321049,0.06750425,0.0014658266,0.0003718124,0.000003538419,0.000028859795,0.00009214339,0.9260075,0.0008763079],"about_ca_topic_score_codex":0.0000948248,"about_ca_topic_score_gemma":4.6302213e-7,"teacher_disagreement_score":0.9353579,"about_ca_system_score_codex":0.00029470472,"about_ca_system_score_gemma":0.0010427006,"threshold_uncertainty_score":0.9992458},"labels":[],"label_agreement":null},{"id":"W1977491200","doi":"10.2165/00129784-200303010-00001","title":"Does Ischemic Preconditioning Afford Clinically Relevant Cardioprotection?","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cardioprotection; Ischemic preconditioning; Pharmacotherapy; Cardiology; Intensive care medicine; Internal medicine; Ischemia","score_opus":0.011532744234204096,"score_gpt":0.29447606598736226,"score_spread":0.2829433217531582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977491200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009309701,0.990734,0.00075902225,0.000047315312,0.0019599132,0.00086363836,0.000016952405,0.000042951706,0.0046452614],"genre_scores_gemma":[0.0004411025,0.9937773,0.0024190685,0.000067749184,0.0024148305,0.000050047303,0.000030897223,0.0001684008,0.000630654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942634,0.00077272725,0.002321912,0.0006340156,0.0015061836,0.00050174235],"domain_scores_gemma":[0.995187,0.00026773982,0.0021230131,0.0012607296,0.0006835182,0.00047800934],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031843197,0.0006970507,0.007751969,0.0005079785,0.00014507952,0.000057994326,0.00029192615,0.00041041587,0.00006416631],"category_scores_gemma":[0.00040468146,0.00038765804,0.018319683,0.0007973352,0.0004166193,0.00013811598,0.00008763696,0.0021159826,0.0000464436],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007522595,0.00005216663,0.0000098816545,0.0031938078,0.016049996,0.0002482799,0.00007525696,0.000025731446,0.000008778276,0.0000013632136,0.0009806729,0.97927886],"study_design_scores_gemma":[0.00090371544,0.00060177274,0.0000015925898,0.013303507,0.025001122,0.014261002,0.00032228554,4.3386797e-7,0.00008073284,0.0000051615534,0.9450373,0.00048138734],"about_ca_topic_score_codex":0.00001923885,"about_ca_topic_score_gemma":8.108424e-8,"teacher_disagreement_score":0.97879744,"about_ca_system_score_codex":0.0004562176,"about_ca_system_score_gemma":0.0014434191,"threshold_uncertainty_score":0.99985754},"labels":[],"label_agreement":null},{"id":"W1982900042","doi":"10.2165/00129784-200606060-00003","title":"Intensive Reduction of Low-Density Lipoprotein-Cholesterol","year":2006,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Cholesterol; Statin; Coronary artery disease; Internal medicine; Randomized controlled trial; Pharmacotherapy; Placebo; Disease; Clinical trial; Cardiology; Intensive care medicine; Pathology","score_opus":0.014788466981190329,"score_gpt":0.28239048422067486,"score_spread":0.2676020172394845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031567805,0.9930286,0.0012062417,0.000051476825,0.0007256966,0.0014580924,0.000018681627,0.00002825862,0.00032619262],"genre_scores_gemma":[0.0061027515,0.9897876,0.0009345204,0.000061343,0.0028070365,0.000030747462,0.0000352003,0.00016883234,0.00007201567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928194,0.0010988924,0.0023992092,0.00060075807,0.0025387332,0.0005429943],"domain_scores_gemma":[0.99175155,0.000082516824,0.002986809,0.0020082302,0.0027320099,0.00043888122],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031152682,0.0007561749,0.010119535,0.00084804016,0.000079971265,0.000031967676,0.00040955737,0.00033565992,0.000009610073],"category_scores_gemma":[0.00033457426,0.00057802204,0.016591499,0.0011550373,0.00062905817,0.00015721154,0.000116613955,0.0015493724,0.000018194334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081252256,0.000097458375,0.0000015175483,0.011155806,0.016193131,0.00027546397,0.00014343493,0.000031137366,0.0000028051727,0.0000032919631,0.0003129571,0.97170174],"study_design_scores_gemma":[0.0015400684,0.001128154,0.00008142395,0.026230656,0.026599806,0.019469885,0.00065699604,8.987939e-7,0.0001656633,0.000010955377,0.92358917,0.0005263218],"about_ca_topic_score_codex":0.0016028218,"about_ca_topic_score_gemma":0.000001894903,"teacher_disagreement_score":0.97117543,"about_ca_system_score_codex":0.0005187837,"about_ca_system_score_gemma":0.0015583928,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null},{"id":"W1984187124","doi":"10.2165/00129784-200101060-00004","title":"Contemporary Management of Children with Atrial Septal Defects","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular and Diving-Related Complications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intracardiac injection; Percutaneous; Surgery; Median sternotomy; Thoracotomy; Septum secundum; Shunt (medical); Volume overload; Cardiology; Internal medicine; Heart failure","score_opus":0.018450823425656227,"score_gpt":0.2756742241101734,"score_spread":0.25722340068451716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984187124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052193797,0.98836976,0.002474108,0.000011196456,0.00017326887,0.0012200705,0.000023569202,0.000030693078,0.007175419],"genre_scores_gemma":[0.009838743,0.98798525,0.0012168905,0.000016292686,0.00066297717,0.000015795975,0.00007205832,0.00012652468,0.00006549029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565834,0.0005028956,0.001373287,0.00046162624,0.0016530431,0.0003507807],"domain_scores_gemma":[0.9961037,0.00009179245,0.0015060605,0.0015025082,0.00044337584,0.0003525833],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012408544,0.0005871332,0.0060972,0.00062280806,0.000065267624,0.000028386828,0.0004510794,0.00015689818,0.000015291029],"category_scores_gemma":[0.000026006388,0.0004232702,0.02765743,0.0015507216,0.00038994467,0.00009984645,0.00011817239,0.0008193847,0.000018782497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012376157,0.000079345504,0.000078645964,0.0018392529,0.17946967,0.00051650894,0.000040758216,0.00015433028,2.2626242e-8,0.000014788866,0.00031367593,0.8173692],"study_design_scores_gemma":[0.004166348,0.0008503368,0.00029378364,0.017091308,0.12284325,0.015604196,0.00020667011,5.5596604e-7,8.5390485e-7,0.0000037751945,0.8384681,0.0004708331],"about_ca_topic_score_codex":0.00007081772,"about_ca_topic_score_gemma":1.3048628e-7,"teacher_disagreement_score":0.83815444,"about_ca_system_score_codex":0.00019559731,"about_ca_system_score_gemma":0.0007946271,"threshold_uncertainty_score":0.9998219},"labels":[],"label_agreement":null},{"id":"W1984682492","doi":"10.2165/00129784-200707010-00006","title":"Current Management of Transient Ischemic Attack","year":2007,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Aspirin; Clopidogrel; Carotid endarterectomy; Dipyridamole; Stroke (engine); Stenosis; Cardiology; Internal medicine; Magnetic resonance imaging; Endarterectomy; Carotid stenting; Surgery; Radiology","score_opus":0.029724797353770288,"score_gpt":0.33460145725482254,"score_spread":0.3048766599010523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984682492","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046183277,0.9943045,0.0011177724,0.000007502915,0.00044649316,0.00071096665,0.00002172396,0.000015219857,0.0029140378],"genre_scores_gemma":[0.0008936819,0.9978795,0.00052182056,0.000020869216,0.00050493784,0.000014651378,0.00003554282,0.00009490263,0.000034060035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953455,0.0002719489,0.0016608012,0.00039596125,0.0018997822,0.00042605033],"domain_scores_gemma":[0.9969245,0.00006266293,0.0010902449,0.0010773763,0.00038896606,0.0004562577],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013267376,0.00056187826,0.0054024775,0.0005823946,0.000032341348,0.000015328424,0.00040466565,0.00008914787,0.00004575601],"category_scores_gemma":[0.0000136066965,0.0004267105,0.01597036,0.0008469823,0.0003471848,0.0000707216,0.00006894885,0.00067383476,0.000022541431],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003492404,0.00022530461,0.0000087546805,0.020113882,0.026881997,0.00013852368,0.000091541806,0.000018311244,1.05109045e-7,0.0000033341553,0.0011423575,0.951341],"study_design_scores_gemma":[0.0011124804,0.00029185653,0.00006517773,0.027451871,0.046143763,0.0015623143,0.00046356345,4.1248617e-7,0.000004660578,2.9897652e-7,0.9225829,0.0003207062],"about_ca_topic_score_codex":0.000005352799,"about_ca_topic_score_gemma":6.046657e-8,"teacher_disagreement_score":0.95102024,"about_ca_system_score_codex":0.00022107898,"about_ca_system_score_gemma":0.00043742024,"threshold_uncertainty_score":0.99981844},"labels":[],"label_agreement":null},{"id":"W1991953589","doi":"10.1007/s40256-014-0103-2","title":"Erratum to: Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management","year":2015,"lang":"en","type":"erratum","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Thiazide; Medicine; Pharmacotherapy; Calcium channel blocker; Calcium channel; Pharmacology; Calcium; Internal medicine; Diuretic","score_opus":0.02907866525999647,"score_gpt":0.2985489857840086,"score_spread":0.26947032052401215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991953589","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053797383,0.2767679,0.071996816,0.07489898,0.28265756,0.0345242,0.0006371254,0.00089281733,0.20382719],"genre_scores_gemma":[0.6399803,0.03815747,0.017193196,0.059690006,0.033872303,0.00138083,0.0008843411,0.0012829994,0.20755856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956223,0.00031144285,0.00086844835,0.00056564814,0.0019926662,0.0006394986],"domain_scores_gemma":[0.9961231,0.00011205593,0.0007278388,0.0005967569,0.0017640505,0.0006761944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021937096,0.0006066946,0.002972526,0.0005981391,0.00016799284,0.000052208405,0.00038619022,0.00023588711,0.000011361104],"category_scores_gemma":[0.00032005162,0.00044560377,0.0028673217,0.0006270196,0.00022914239,0.000101930134,0.00025115986,0.0010696041,0.00002545375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070519245,0.00037515696,0.0000030489377,0.00040750185,0.017073546,0.00072650716,0.0003213158,0.00012613856,0.000024389552,0.000006286819,0.9401364,0.04009454],"study_design_scores_gemma":[0.006058078,0.00394734,0.00055513077,0.0010270744,0.012235873,0.0004980225,0.0012704467,0.0003428608,0.00006551298,0.00015906354,0.9733106,0.00053001015],"about_ca_topic_score_codex":0.000042600663,"about_ca_topic_score_gemma":5.98668e-7,"teacher_disagreement_score":0.5861829,"about_ca_system_score_codex":0.00046778272,"about_ca_system_score_gemma":0.00024882343,"threshold_uncertainty_score":0.99979955},"labels":[],"label_agreement":null},{"id":"W1992908766","doi":"10.2165/10061630-000000000-00000","title":"Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"AstraZeneca","keywords":"Dyslipidemia; Medicine; Atorvastatin; Statin; Rosuvastatin; Simvastatin; Internal medicine; Pharmacology; Type 2 Diabetes Mellitus; Fixed-dose combination; Combination therapy; Gastroenterology; Fenofibrate; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.005073515122734928,"score_gpt":0.22884284159155013,"score_spread":0.2237693264688152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992908766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534893,0.0035641731,0.00021542418,0.0000779179,0.00007627732,0.0006303882,0.000011339141,0.000009242319,0.00006630198],"genre_scores_gemma":[0.99474883,0.00086138176,0.004116411,0.00008533811,0.00011064991,0.0000059316253,0.000010847309,0.0000532164,0.0000074033806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99728066,0.000323193,0.0006674279,0.00032816295,0.0010271963,0.00037336594],"domain_scores_gemma":[0.997897,0.00014154267,0.0004643863,0.0006074776,0.0004917487,0.00039783897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014957091,0.00029142576,0.0018112854,0.00023570996,0.00006253614,0.000027309794,0.000106507236,0.00007438054,0.000008667318],"category_scores_gemma":[0.00017868417,0.00017990364,0.00029494133,0.00051526056,0.0005081293,0.00015272427,0.000035408117,0.00051652367,6.690672e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029406205,0.00050374685,0.1638466,0.0007347428,0.009880019,0.00021686786,0.0019856228,0.0004880213,0.00061487715,0.0000101494,0.000026531425,0.79228663],"study_design_scores_gemma":[0.031906173,0.0100609,0.9468952,0.0009766356,0.0021098503,0.00027732342,0.0009544776,0.00008678041,0.0036535591,0.000006922575,0.002583256,0.0004889457],"about_ca_topic_score_codex":0.00007691649,"about_ca_topic_score_gemma":0.000012162397,"teacher_disagreement_score":0.7917977,"about_ca_system_score_codex":0.000051138763,"about_ca_system_score_gemma":0.00047012442,"threshold_uncertainty_score":0.7336257},"labels":[],"label_agreement":null},{"id":"W1992920746","doi":"10.2165/00129784-200101060-00007","title":"Clopidogrel","year":2001,"lang":"fr","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Clopidogrel; Pharmacotherapy; Internal medicine; Cardiology; Aspirin","score_opus":0.006937974988336916,"score_gpt":0.2398271040812727,"score_spread":0.23288912909293577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992920746","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2765086,0.6960417,0.015058269,0.0016089636,0.0042215413,0.0002497008,0.000012334734,0.000033061755,0.0062658167],"genre_scores_gemma":[0.7247837,0.26323202,0.0012123857,0.0007895988,0.007996969,0.0000044170074,0.000005789835,0.00011494995,0.001860118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994231,0.0010855655,0.0011276057,0.00042877093,0.002137146,0.0009899299],"domain_scores_gemma":[0.99619466,0.00017215405,0.0006503932,0.0011861392,0.0008136243,0.0009830251],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0029976536,0.00053627096,0.002693909,0.00039551838,0.0001462679,0.00007342236,0.00048747807,0.00017201091,0.00050703937],"category_scores_gemma":[0.00018714154,0.00049337663,0.010416782,0.0012612081,0.0013233017,0.00041566236,0.000073495845,0.00087461737,0.00033602116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086954626,0.0003270312,0.0029079923,0.00011341104,0.046476718,0.007179998,0.0007010962,0.002633307,0.00002458241,0.00020892406,0.0023356797,0.9362217],"study_design_scores_gemma":[0.0047926456,0.001489135,0.0039288015,0.0010368665,0.013518597,0.022377798,0.0045603514,0.000054784992,0.00017846358,0.000106471096,0.9474456,0.00051050435],"about_ca_topic_score_codex":0.00016676701,"about_ca_topic_score_gemma":5.255469e-7,"teacher_disagreement_score":0.9451099,"about_ca_system_score_codex":0.0003109218,"about_ca_system_score_gemma":0.0007281845,"threshold_uncertainty_score":0.9997518},"labels":[],"label_agreement":null},{"id":"W1996384645","doi":"10.1007/s40256-013-0049-9","title":"New Drug Avenues for Cardioprotection in Patients with Acute Myocardial Infarction","year":2013,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Cardioprotection; Medicine; Myocardial infarction; Reperfusion injury; Cardiology; Heart failure; Internal medicine; Pharmacology; Ischemia; Intensive care medicine","score_opus":0.0027229400250250784,"score_gpt":0.19613458172095594,"score_spread":0.19341164169593086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996384645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9002563,0.005608603,0.007064003,0.07713064,0.004188615,0.0048109386,0.00007149951,0.00007750582,0.00079193676],"genre_scores_gemma":[0.65529627,0.008539698,0.030281935,0.16481155,0.13062757,0.0007988228,0.0018620666,0.0019186288,0.0058634514],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964863,0.00022805353,0.00069536635,0.00043731366,0.0016902873,0.00046264887],"domain_scores_gemma":[0.9974528,0.00006802131,0.0007379235,0.0006674087,0.0008788061,0.00019505786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006307311,0.00046393854,0.0023860203,0.0006211153,0.00006837671,0.00005131095,0.00016659233,0.00033855837,0.0000095625865],"category_scores_gemma":[0.00005377407,0.00034919413,0.0036654966,0.00045674044,0.00014795468,0.00020334292,0.000042372234,0.0019320487,0.000009293304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002026098,0.000058332233,0.0040912866,0.00022732481,0.030620016,0.00040483833,0.00088802085,0.00044817556,0.00007789806,3.414971e-7,0.5882303,0.37292737],"study_design_scores_gemma":[0.008504762,0.0015394918,0.0074866614,0.000742466,0.009400144,0.0010118041,0.00017692478,0.000004346036,0.0004100697,0.000013211665,0.9701612,0.0005489292],"about_ca_topic_score_codex":0.0005785602,"about_ca_topic_score_gemma":5.6023634e-7,"teacher_disagreement_score":0.3819309,"about_ca_system_score_codex":0.00048282096,"about_ca_system_score_gemma":0.0005964019,"threshold_uncertainty_score":0.999896},"labels":[],"label_agreement":null},{"id":"W1997002994","doi":"10.2165/00129784-200505060-00002","title":"ACE Inhibitors in Heart Failure","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; Lisinopril; ACE inhibitor; Internal medicine; Heart failure; Cardiology; Hazard ratio; Valsartan; Angiotensin-converting enzyme; Ramipril; Myocardial infarction; Placebo; Blood pressure; Confidence interval","score_opus":0.01400973644410922,"score_gpt":0.2939727673296045,"score_spread":0.27996303088549523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997002994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047055128,0.9964649,0.00004258954,0.0021029336,0.00021403802,0.0007473639,0.0000025760062,0.000020381762,0.00035812866],"genre_scores_gemma":[0.0001734555,0.9898842,0.008141468,0.0001371085,0.0013236773,0.00002630322,0.000011359587,0.00008869843,0.00021374642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964776,0.00046932188,0.0011917927,0.00035052854,0.0010703204,0.0004404135],"domain_scores_gemma":[0.99816376,0.00009205541,0.00055639213,0.0007189943,0.00014343673,0.0003253817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014066282,0.00051554467,0.005381964,0.00090743386,0.000031196752,0.000030831696,0.00021101702,0.00014600472,0.0000413015],"category_scores_gemma":[0.00006091397,0.0003722737,0.0060926173,0.0009784397,0.00016172917,0.00012442845,0.00007519846,0.00089408865,0.00010619846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001460395,0.00009781344,0.000017119173,0.0011225408,0.005662357,0.00046909018,0.00011500542,0.000018346267,5.3813043e-8,0.0000034717418,0.015677847,0.97680175],"study_design_scores_gemma":[0.001001271,0.00038169575,0.000008113523,0.009804002,0.00848888,0.0016231677,0.0003144788,3.5963293e-7,8.385107e-7,0.0000010185446,0.9780995,0.0002766538],"about_ca_topic_score_codex":0.00004911546,"about_ca_topic_score_gemma":0.000003814003,"teacher_disagreement_score":0.9765251,"about_ca_system_score_codex":0.0005265094,"about_ca_system_score_gemma":0.0005715779,"threshold_uncertainty_score":0.9998729},"labels":[],"label_agreement":null},{"id":"W2024206888","doi":"10.1007/s40256-013-0018-3","title":"Pharmacokinetics and Pharmacodynamics of the Antiplatelet Combination Aspirin (Acetylsalicylic Acid) Plus Extended-Release Dipyridamole Are Not Altered by Coadministration with the Potent CYP2C19 Inhibitor Omeprazole","year":2013,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celerion (Canada)","funders":"","keywords":"Omeprazole; Medicine; Proton-pump inhibitor; Pharmacology; Pharmacodynamics; Pharmacokinetics; Dipyridamole; Aspirin; Drug interaction; CYP2C19; Crossover study; Clopidogrel; Anesthesia; Internal medicine","score_opus":0.004512241784459435,"score_gpt":0.21755519109785537,"score_spread":0.21304294931339593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024206888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473585,0.008172095,0.003936451,0.0021513756,0.00017147181,0.00071777415,0.000037129717,0.000018117233,0.000059718062],"genre_scores_gemma":[0.9960936,0.0026805524,0.00011047199,0.0007514644,0.00024039633,0.00002875037,0.000015773965,0.000051002797,0.00002802554],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971002,0.00044547828,0.0005611365,0.0002722519,0.0013236022,0.00029735162],"domain_scores_gemma":[0.9977215,0.00006571501,0.00079687167,0.00057447003,0.00059536134,0.00024606814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007271917,0.00031366578,0.0009594146,0.00010314265,0.0001650696,0.00006770525,0.00028369005,0.000056853827,0.000013893343],"category_scores_gemma":[0.000033439283,0.00018250367,0.0011658291,0.0004431502,0.0007377977,0.0002355213,0.00006601789,0.00045294306,0.0000028634433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054471493,0.0015577028,0.004843868,0.0006253248,0.039171375,0.00032066397,0.0022698103,0.0101624355,0.11510039,0.00010955498,0.0063106567,0.8140811],"study_design_scores_gemma":[0.0701625,0.0073673944,0.15262786,0.0019540687,0.030137219,0.010346467,0.022063255,0.012679852,0.6249765,0.00012037298,0.065219834,0.0023446693],"about_ca_topic_score_codex":0.000056800225,"about_ca_topic_score_gemma":7.4500804e-7,"teacher_disagreement_score":0.8117364,"about_ca_system_score_codex":0.00008568155,"about_ca_system_score_gemma":0.00020277983,"threshold_uncertainty_score":0.7442284},"labels":[],"label_agreement":null},{"id":"W2026737636","doi":"10.2165/00129784-200808020-00001","title":"Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia","year":2008,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Niacin; Simvastatin; Medicine; Dyslipidemia; Tolerability; Internal medicine; Triglyceride; Lovastatin; Pharmacology; Gastroenterology; Urology; Adverse effect; Endocrinology; Cholesterol; Obesity","score_opus":0.004725128016476281,"score_gpt":0.22181609393772764,"score_spread":0.21709096592125135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026737636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384123,0.0043569673,0.001206628,0.000059831993,0.000029098896,0.00044118153,0.0000052214573,0.0000044782983,0.000055332832],"genre_scores_gemma":[0.996724,0.0020516673,0.0011037684,0.000035893125,0.000047201356,0.0000021660064,0.0000062091995,0.00002480523,0.0000043020186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974421,0.0003483522,0.00076633313,0.00021009555,0.0010321566,0.00020092553],"domain_scores_gemma":[0.9981911,0.000119100565,0.0005898796,0.00041161617,0.00047175723,0.00021653129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012869833,0.00017635112,0.0015093946,0.00028216306,0.00003941616,0.0000037023783,0.000068332134,0.000045419074,0.000002920161],"category_scores_gemma":[0.00022516242,0.00013424481,0.00051436515,0.00042091892,0.0004605515,0.00011888877,0.00003180794,0.0002720181,1.6862654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033833352,0.00048273287,0.52995586,0.0003329862,0.0029347138,0.00014660304,0.0014831006,0.00020621842,0.000038948743,0.000014408836,0.0000055561977,0.46101552],"study_design_scores_gemma":[0.014900809,0.002206686,0.9806134,0.00048534616,0.00072977284,0.00032388823,0.00026441127,0.000015369927,0.0002500963,0.0000042112906,0.0000832384,0.00012273113],"about_ca_topic_score_codex":0.00016159302,"about_ca_topic_score_gemma":0.0000020428906,"teacher_disagreement_score":0.4608928,"about_ca_system_score_codex":0.000073110656,"about_ca_system_score_gemma":0.00022159927,"threshold_uncertainty_score":0.54743445},"labels":[],"label_agreement":null},{"id":"W2034365627","doi":"10.2165/00129784-200505050-00002","title":"Anticoagulant Use in Patients with Chronic Renal Impairment","year":2005,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Anticoagulant; Anticoagulant therapy; Chronic renal failure; Internal medicine; Cardiology","score_opus":0.02260685290461545,"score_gpt":0.28586271534560936,"score_spread":0.2632558624409939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034365627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04349438,0.95508146,0.000057205823,0.000024896799,0.00015216233,0.0010539955,0.000014999646,0.000016395332,0.00010449401],"genre_scores_gemma":[0.030176463,0.9680703,0.0008788949,0.000044104047,0.0006165219,0.000018358749,0.000037189202,0.00013670941,0.000021401154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953987,0.00055037794,0.0014656193,0.00049227464,0.0014554184,0.0006375805],"domain_scores_gemma":[0.99689204,0.00010907748,0.001150437,0.001033849,0.0003576728,0.00045692522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096613454,0.00068328774,0.0071809473,0.0007855516,0.000048768896,0.000060794988,0.0003547852,0.0001694031,0.000034287674],"category_scores_gemma":[0.00005752655,0.00044956608,0.0036797074,0.0009563498,0.00027122544,0.00026271664,0.00009354378,0.0012046617,0.00003427372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010657706,0.00036260163,0.0013532541,0.0011055587,0.012302501,0.00034743774,0.00008821171,0.000053214153,2.4865008e-7,0.0000021933874,0.000045633777,0.98423254],"study_design_scores_gemma":[0.004316669,0.002959947,0.017135391,0.02074667,0.014921815,0.00094804907,0.000031758856,0.0000015300511,0.0000022139827,4.7103453e-7,0.93838507,0.00055041595],"about_ca_topic_score_codex":0.00019535139,"about_ca_topic_score_gemma":0.000008912495,"teacher_disagreement_score":0.98368216,"about_ca_system_score_codex":0.0015177293,"about_ca_system_score_gemma":0.0018386121,"threshold_uncertainty_score":0.9997956},"labels":[],"label_agreement":null},{"id":"W2035728262","doi":"10.2165/11587000-000000000-00000","title":"Dose-Dependent Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice-Based Study","year":2011,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dr. Georges-L.-Dumont University Hospital Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Perindopril; Tolerability; Internal medicine; Indapamide; Adverse effect; Population; Observational study; Blood pressure","score_opus":0.059910552487420075,"score_gpt":0.28884971815201316,"score_spread":0.22893916566459308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035728262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838509,0.014680791,0.00010215596,0.0004797399,0.00010539348,0.00045289422,0.000004392787,0.000009416944,0.00031433013],"genre_scores_gemma":[0.9947282,0.0006166213,0.0034088534,0.001071871,0.00013070679,0.000007981632,0.0000011466726,0.000023802992,0.0000108009845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971968,0.0005126654,0.00079085806,0.00028843267,0.00096918875,0.00024206439],"domain_scores_gemma":[0.9973077,0.00027539747,0.0004908723,0.0004850913,0.0012882461,0.00015268005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001981421,0.00021000426,0.0018440319,0.00022337397,0.000058754456,0.000010866276,0.00012231806,0.00004483262,0.000015667158],"category_scores_gemma":[0.0005276052,0.00016128631,0.0005508683,0.00029279463,0.00021194435,0.0001675352,0.00007945377,0.00036352858,0.0000012261926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010197069,0.014370137,0.8323274,0.0002214346,0.03710456,0.0037609069,0.028786464,0.00067647616,0.0011958563,0.00004877784,0.00039336205,0.070917554],"study_design_scores_gemma":[0.012016169,0.0034360825,0.95513576,0.00012949512,0.006048326,0.00055328506,0.016003815,0.000047887625,0.0005564905,0.000008820183,0.005849841,0.00021399991],"about_ca_topic_score_codex":0.0005391725,"about_ca_topic_score_gemma":0.000011123602,"teacher_disagreement_score":0.12280838,"about_ca_system_score_codex":0.00002581712,"about_ca_system_score_gemma":0.00024173359,"threshold_uncertainty_score":0.6577065},"labels":[],"label_agreement":null},{"id":"W2037319161","doi":"10.2165/00129784-200404050-00005","title":"Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Augmentium Pharma Consulting (Canada); Health Sciences Centre; Toronto East General Hospital; Jewish General Hospital; Royal Jubilee Hospital; Bausch Health (Canada); Sunnybrook Health Science Centre","funders":"","keywords":"Fondaparinux; Medicine; Orthopedic surgery; Low molecular weight heparin; Emergency medicine; Surgery; Intensive care medicine; Venous thromboembolism; Heparin; Thrombosis","score_opus":0.0365783578006559,"score_gpt":0.3374377838595827,"score_spread":0.3008594260589268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037319161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046487864,0.9506741,0.00037938458,0.000016052316,0.00066315464,0.0016669704,0.00003500289,0.000005009648,0.000072424766],"genre_scores_gemma":[0.110676065,0.88880634,0.00012113868,0.000015995223,0.00014709828,0.000091785354,0.00007549206,0.00005946199,0.0000066495354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562836,0.00044038496,0.002373775,0.00035305932,0.00084751577,0.0003568788],"domain_scores_gemma":[0.9947498,0.00066533114,0.0033076901,0.0007657746,0.00037686498,0.00013453656],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002779084,0.00042299245,0.008900421,0.0016612441,0.000040713974,0.000007639165,0.00034718035,0.00010325225,0.000029933755],"category_scores_gemma":[0.00018288361,0.00030236223,0.012048198,0.0016605817,0.00020335968,0.00010647557,0.00009944978,0.00035881074,0.0000019754652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015284262,0.00073260587,0.0005100307,0.0047831237,0.09356566,0.000007662848,0.00021027266,0.0018932398,8.282183e-8,0.0000144133555,0.00007510864,0.89805496],"study_design_scores_gemma":[0.0073623965,0.0017242901,0.026317498,0.01629777,0.44329393,0.0000293992,0.00053768104,0.000031954427,0.000008030615,0.000021530479,0.5037623,0.0006132017],"about_ca_topic_score_codex":0.00041428983,"about_ca_topic_score_gemma":0.000013637346,"teacher_disagreement_score":0.89744174,"about_ca_system_score_codex":0.00045125722,"about_ca_system_score_gemma":0.0009745424,"threshold_uncertainty_score":0.99994284},"labels":[],"label_agreement":null},{"id":"W2041812856","doi":"10.2165/00129784-200202050-00004","title":"Optimizing the Use of Abciximab and Intracoronary Stents in Patients with Acute ST Elevation Myocardial Infarction","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Abciximab; Medicine; Myocardial infarction; Cardiology; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Stent; Angioplasty; Thrombolysis; Revascularization; Restenosis","score_opus":0.022432613515089104,"score_gpt":0.2599481232722334,"score_spread":0.23751550975714428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041812856","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045598436,0.9526508,0.0006995101,0.00003267421,0.00019344741,0.0007423582,0.00005572165,0.000004197893,0.00002284456],"genre_scores_gemma":[0.013168842,0.9850168,0.0015473263,0.000027083175,0.00012752641,0.0000116104575,0.000050294322,0.000040988405,0.000009480108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755406,0.00035439813,0.0009296246,0.00020068153,0.0007805521,0.00018069221],"domain_scores_gemma":[0.9978293,0.00022629452,0.0010198461,0.00041033144,0.0004181691,0.00009605619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004435987,0.00027496734,0.002038766,0.00039449238,0.00004090723,0.000029336703,0.00012025432,0.0000765978,0.000012529353],"category_scores_gemma":[0.00010123162,0.00017074542,0.0015437466,0.0004898325,0.00022652581,0.00023312483,0.00005647827,0.0005322632,0.0000011379663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015411049,0.00017095581,0.0017774857,0.00044172944,0.008257486,0.000067992834,0.00015049544,0.0003334479,2.0929528e-8,0.0000011429573,0.000057159916,0.988588],"study_design_scores_gemma":[0.004604241,0.0036810292,0.039856017,0.018815229,0.03326615,0.0014286471,0.00035551444,0.00006577627,2.2897095e-7,0.0000020699745,0.8975162,0.00040893425],"about_ca_topic_score_codex":0.000052063668,"about_ca_topic_score_gemma":7.5280167e-7,"teacher_disagreement_score":0.988179,"about_ca_system_score_codex":0.00018243727,"about_ca_system_score_gemma":0.00015064783,"threshold_uncertainty_score":0.69627964},"labels":[],"label_agreement":null},{"id":"W2043229647","doi":"10.2165/00129784-200404010-00001","title":"A Perspective on the Toxicological Mechanisms Possibly Contributing to the Failure of Oral Glycoprotein IIb/IIIa Antagonists in the Clinic","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pharmacotherapy; Pharmacology; Perspective (graphical); Intensive care medicine; P-glycoprotein; Internal medicine; Biochemistry; Multiple drug resistance","score_opus":0.04084037619252233,"score_gpt":0.35544704085723916,"score_spread":0.3146066646647168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043229647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014101888,0.96536946,0.0008388639,0.012809677,0.00043456978,0.005250573,0.000054801705,0.000023441287,0.0011167246],"genre_scores_gemma":[0.41429988,0.58307195,0.0007541134,0.0011675466,0.00046460956,0.00013108719,0.0000061165947,0.00008587842,0.00001882473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99242383,0.0030766013,0.0015922382,0.00051897456,0.0016353922,0.0007529669],"domain_scores_gemma":[0.99535793,0.0010704444,0.0014225282,0.0013730227,0.00055023975,0.00022585118],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009527309,0.0006369697,0.0054140124,0.00031644397,0.00027396018,0.00008794622,0.0013737475,0.00026207624,0.00005077226],"category_scores_gemma":[0.0014500697,0.00026499893,0.0054910397,0.0017845152,0.0005403693,0.000063358355,0.00022437664,0.00256327,0.000051992545],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005491655,0.00077533966,0.00001584906,0.0011781994,0.023434903,0.0012465726,0.0068064136,0.00008397452,0.000055272336,0.006433935,0.00028456023,0.95913583],"study_design_scores_gemma":[0.00501893,0.011028242,0.0008880842,0.029680211,0.022747505,0.006695159,0.040354777,0.0000022806043,0.00027574884,0.0013368072,0.88085574,0.0011165065],"about_ca_topic_score_codex":0.00045760162,"about_ca_topic_score_gemma":0.00001982209,"teacher_disagreement_score":0.9580193,"about_ca_system_score_codex":0.0010240149,"about_ca_system_score_gemma":0.0016253992,"threshold_uncertainty_score":0.9999802},"labels":[],"label_agreement":null},{"id":"W2062044681","doi":"10.2165/00129784-200303060-00004","title":"Cancer of the Heart","year":2003,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Medical physics; Internal medicine; Cardiology","score_opus":0.016083180398375398,"score_gpt":0.3086130721081177,"score_spread":0.2925298917097423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062044681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024840105,0.9969223,0.00002442239,0.00007141226,0.0009730589,0.0003713899,0.000018862278,0.0000042034,0.0013659262],"genre_scores_gemma":[0.0006983067,0.9981244,0.00017756857,0.00013480269,0.0006391026,0.000010787294,0.0000012944881,0.000071060604,0.00014265094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679023,0.0006077464,0.00097085885,0.00020801665,0.0011680046,0.00025513046],"domain_scores_gemma":[0.9972088,0.00008570167,0.0011609338,0.0009834039,0.00037718847,0.00018398189],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.001168368,0.00033301793,0.0059383973,0.00018840958,0.00004028362,0.000011179015,0.00027193705,0.00008617502,0.000039832074],"category_scores_gemma":[0.0000767507,0.00018681936,0.015363454,0.00083615363,0.00042591375,0.000035463843,0.000057343146,0.0007548799,0.000005741411],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009026287,0.000032862252,0.00003583189,0.0021135716,0.011848949,0.000042237578,0.000062124054,0.00001479773,3.7963085e-7,0.000010890152,0.0015839527,0.98424536],"study_design_scores_gemma":[0.00039174123,0.00013962471,0.00008619326,0.01027417,0.021256613,0.0038230598,0.0001020729,7.403233e-8,0.000007854414,0.000004199805,0.9637527,0.00016168803],"about_ca_topic_score_codex":0.00012386817,"about_ca_topic_score_gemma":3.05031e-7,"teacher_disagreement_score":0.9840837,"about_ca_system_score_codex":0.00019799045,"about_ca_system_score_gemma":0.001469217,"threshold_uncertainty_score":0.9944974},"labels":[],"label_agreement":null},{"id":"W206416980","doi":"10.2165/00129784-200606030-00003","title":"Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Sirolimus; Restenosis; Stent; Angioplasty; Coronary arteries; Internal medicine; Cost effectiveness; Relative risk; Surgery; Artery; Confidence interval","score_opus":0.0050900751739156634,"score_gpt":0.21380329251385716,"score_spread":0.2087132173399415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W206416980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978311,0.0013424307,0.00016231733,0.000037684713,0.0002375257,0.00026016132,0.0000139710955,0.0000012399527,0.00011359169],"genre_scores_gemma":[0.9996461,0.00017887777,0.00007817168,0.00002299439,0.000051219493,0.0000046305977,0.0000028569425,0.000012338493,0.00000277158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980425,0.00051493145,0.0005560786,0.00010489218,0.00060127914,0.0001803024],"domain_scores_gemma":[0.99875826,0.00031947464,0.00037625054,0.00026816243,0.00022348095,0.000054366574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008668398,0.00010535598,0.00065497484,0.00012895685,0.000022392838,0.000004079895,0.00012507492,0.00001720981,0.000004027688],"category_scores_gemma":[0.00022869158,0.000075143755,0.000638783,0.00043220384,0.00008007222,0.000038238257,0.000040882573,0.00027308747,2.9674294e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001364191,0.00016890676,0.8989077,0.000047108453,0.00032722618,0.00007652662,0.000053218868,0.027729562,0.0000062675185,0.0000058020714,0.000019069334,0.07252216],"study_design_scores_gemma":[0.0033852297,0.00025773005,0.99375314,0.0007112178,0.00033338496,0.000040290895,0.0005966861,0.00005958619,0.0002832747,0.000021854261,0.00048772423,0.000069865855],"about_ca_topic_score_codex":0.8012185,"about_ca_topic_score_gemma":0.11568994,"teacher_disagreement_score":0.6855286,"about_ca_system_score_codex":0.000630389,"about_ca_system_score_gemma":0.0005321025,"threshold_uncertainty_score":0.9004464},"labels":[],"label_agreement":null},{"id":"W2067005179","doi":"10.1007/s40256-013-0009-4","title":"Pharmacologic Treatment of Hypertension in Patients With Chronic Kidney Disease","year":2013,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Kidney disease; Etiology; Disease; Intensive care medicine; Blood pressure; Pharmacotherapy; Population; Internal medicine; Kidney","score_opus":0.028158210346119036,"score_gpt":0.2755324716003946,"score_spread":0.24737426125427558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067005179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027337505,0.9959306,0.000004627265,0.00009673292,0.0001668118,0.0009859762,0.000020066056,0.000007714029,0.000053725194],"genre_scores_gemma":[0.005536868,0.99352884,0.00018436661,0.0002725731,0.00032254428,0.00004097987,0.00002558836,0.00005678924,0.00003145262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972732,0.00036483438,0.0009006373,0.00030425898,0.00086699676,0.0002900367],"domain_scores_gemma":[0.9973673,0.00010770659,0.00091345777,0.0005406203,0.0006163963,0.00045447057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024797433,0.0004672791,0.006566787,0.0004223894,0.000032808708,0.0000080569835,0.00014389162,0.00006368728,0.000030017534],"category_scores_gemma":[0.00004461638,0.00024696387,0.002880013,0.000455962,0.00027424615,0.00007168092,0.000043278906,0.0002907489,0.000010897114],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023616399,0.000620142,0.00048460334,0.0022442013,0.022509633,0.00042369703,0.000054283104,0.000011679225,2.242434e-7,1.9895043e-7,0.0012256602,0.9721895],"study_design_scores_gemma":[0.0050023356,0.003008173,0.000974321,0.008007861,0.0649956,0.00015163797,0.000036747413,0.0000010092448,0.000002165267,4.872899e-7,0.91759205,0.00022758286],"about_ca_topic_score_codex":0.00008450939,"about_ca_topic_score_gemma":2.0023212e-7,"teacher_disagreement_score":0.9719619,"about_ca_system_score_codex":0.0001816673,"about_ca_system_score_gemma":0.0010191568,"threshold_uncertainty_score":0.9999983},"labels":[],"label_agreement":null},{"id":"W2067166093","doi":"10.1007/s40256-014-0087-y","title":"Thiazide-Like/Calcium Channel Blocker Agents: A Major Combination for Hypertension Management","year":2014,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Servier","keywords":"Medicine; Amlodipine; Blood pressure; Thiazide; Atenolol; Calcium channel blocker; Indapamide; Internal medicine; Pharmacology; Renin–angiotensin system; Aldosterone; Intensive care medicine; Combination therapy; Diuretic; Guideline; Cardiology","score_opus":0.039783797245563524,"score_gpt":0.30328650319669914,"score_spread":0.2635027059511356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067166093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015342472,0.9932407,0.0031783045,0.0003985351,0.0010644038,0.0014549766,0.000012606253,0.000033796892,0.00060134986],"genre_scores_gemma":[0.00047751868,0.9939888,0.0019703598,0.0016948447,0.0011077045,0.000110111,0.000042133815,0.00014174242,0.000466748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959442,0.0004159744,0.0013364826,0.00051077,0.0013276201,0.0004649549],"domain_scores_gemma":[0.9961905,0.00024970633,0.0012341269,0.00090375566,0.001137268,0.000284625],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019017442,0.0006289422,0.007439529,0.00065497495,0.0001658966,0.00004032954,0.00032548702,0.00018876097,0.0000088503775],"category_scores_gemma":[0.000090088906,0.00043764457,0.0070904773,0.00049689575,0.00020997511,0.000084081876,0.00016092061,0.00056885806,0.000031932672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008632855,0.00017551146,7.0809085e-7,0.0076562935,0.04642671,0.00029378483,0.000098028344,0.000004604894,1.491289e-7,0.000021192378,0.036607523,0.9086292],"study_design_scores_gemma":[0.002607138,0.00066255947,0.000008554314,0.009504396,0.10245971,0.0021204355,0.00036143692,0.000019524694,0.0000019055913,0.000023745948,0.8818561,0.0003745324],"about_ca_topic_score_codex":0.000016837526,"about_ca_topic_score_gemma":1.604526e-7,"teacher_disagreement_score":0.9082546,"about_ca_system_score_codex":0.000079700134,"about_ca_system_score_gemma":0.00014751608,"threshold_uncertainty_score":0.99980754},"labels":[],"label_agreement":null},{"id":"W2079420595","doi":"10.2165/00129784-200303030-00006","title":"New Anticoagulants","year":2003,"lang":"fr","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Argatroban; Medicine; Discovery and development of direct thrombin inhibitors; Fondaparinux; Tissue factor; Hirudin; Factor IXa; Ximelagatran; Dabigatran; Prothrombinase; Thrombin; Direct thrombin inhibitor; Lepirudin; Coagulation; Pharmacology; Rivaroxaban; Thrombomodulin; Tissue factor pathway inhibitor; Anticoagulant; Antithrombin; Factor X; Warfarin; Heparin; Thrombosis; Immunology; Internal medicine; Atrial fibrillation; Platelet; Venous thromboembolism","score_opus":0.026320322877314017,"score_gpt":0.2952242072185761,"score_spread":0.2689038843412621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079420595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014612262,0.9584551,0.031509154,0.0001807259,0.0056725973,0.00057754805,0.000011018357,0.000022417913,0.0034253274],"genre_scores_gemma":[0.001994568,0.97964144,0.012276934,0.00042255598,0.003963347,0.000004362908,0.000013066297,0.00020766402,0.0014760505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916408,0.0018709821,0.002380619,0.0006033286,0.0025465859,0.0009576617],"domain_scores_gemma":[0.99363947,0.00025198184,0.0024262862,0.0014455317,0.0007263911,0.0015103696],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0032738023,0.000982083,0.009300003,0.0007179869,0.00012466541,0.00009598755,0.0006673447,0.00035407525,0.0011023344],"category_scores_gemma":[0.00023829885,0.0008265936,0.0110356705,0.0015763231,0.00037772895,0.0002195873,0.000088581815,0.0015177462,0.0008349843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028026805,0.00013934808,0.000020624488,0.001849458,0.03273434,0.0005297978,0.00024012424,0.00009896088,0.0000057399425,0.000629679,0.0015640296,0.9621599],"study_design_scores_gemma":[0.002219811,0.0010735455,0.00006230245,0.016181594,0.045277074,0.008088482,0.0005925497,0.000007743096,0.000066677596,0.000104421706,0.92564416,0.00068161945],"about_ca_topic_score_codex":0.00011633488,"about_ca_topic_score_gemma":3.743974e-7,"teacher_disagreement_score":0.96147823,"about_ca_system_score_codex":0.0004623114,"about_ca_system_score_gemma":0.0032264965,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W2087243140","doi":"10.1007/bf03256591","title":"Non-Hemodynamic Effects of Organic Nitrates and the Distinctive Characteristics of Pentaerithrityl Tetranitrate","year":2009,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; Mount Sinai Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Isosorbide dinitrate; Medicine; Isosorbide mononitrate; Angina; Heart failure; Hemodynamics; Intensive care medicine; Cardiology; Pharmacology; Internal medicine","score_opus":0.0033790865087181777,"score_gpt":0.23436425466507746,"score_spread":0.23098516815635928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087243140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09070432,0.9078011,0.00022324074,0.000015830847,0.0002056581,0.00075344415,0.00001335999,0.0000052088635,0.000277825],"genre_scores_gemma":[0.20806953,0.79145104,0.000117630916,0.000013684589,0.00026934204,0.000005367815,0.000012992952,0.000048164526,0.000012228094],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99688077,0.00054685905,0.0012416096,0.0002618867,0.00083418644,0.00023470611],"domain_scores_gemma":[0.9963739,0.00053984736,0.0018116182,0.00060552097,0.00050522643,0.00016387951],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014314314,0.0004577991,0.006944551,0.00023780516,0.000052916486,0.000016480943,0.00023384683,0.00014889563,0.0000040567],"category_scores_gemma":[0.00022464136,0.0002589952,0.005096475,0.0005656449,0.0010689504,0.000052481733,0.000067042485,0.0008443113,0.0000011993934],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018711356,0.00008984492,0.000028545026,0.00968158,0.008669529,0.00014362506,0.00041828922,4.691075e-7,0.00022166052,0.000003987876,0.000006241125,0.9805491],"study_design_scores_gemma":[0.0338537,0.008962866,0.0078606475,0.21792038,0.39599535,0.036372967,0.0040152445,0.000045623216,0.006620287,0.00009011413,0.28514206,0.0031207802],"about_ca_topic_score_codex":0.000029851462,"about_ca_topic_score_gemma":1.9850303e-7,"teacher_disagreement_score":0.9774283,"about_ca_system_score_codex":0.00009200853,"about_ca_system_score_gemma":0.0005017401,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2183532679","doi":"10.2165/00129784-200202030-00003","title":"Cardiovascular Risk in Patients with Early Renal Insufficiency","year":2002,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Internal medicine; Population; Risk factor; Coronary artery disease; Blood pressure; Creatinine; Incidence (geometry); Renal function; Kidney disease; Stroke (engine); Cardiology","score_opus":0.013921998754039435,"score_gpt":0.23602285559176903,"score_spread":0.2221008568377296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183532679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024285968,0.9957642,0.0001004712,0.0000118318,0.00022568698,0.0007360795,0.000022017137,0.000020659332,0.000690463],"genre_scores_gemma":[0.0044268095,0.9941477,0.000661783,0.00006625015,0.0005021108,0.000020176785,0.000008330698,0.00012763846,0.000039187667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993765,0.0009798488,0.0014436594,0.0006047553,0.0026316359,0.00057509437],"domain_scores_gemma":[0.9959777,0.00014240088,0.0012360916,0.0014109103,0.00090021,0.0003327105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017116802,0.0007363592,0.01038783,0.0009495162,0.00010501166,0.000039253646,0.0004014464,0.00019714802,0.000015006217],"category_scores_gemma":[0.00014150322,0.00046715126,0.008780537,0.0015119595,0.00043443748,0.00014946942,0.00011507574,0.001739487,0.000031620923],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008690303,0.0003722609,0.0008421296,0.00091613247,0.060437102,0.000635303,0.00028806427,0.00005628729,2.8393004e-9,6.424447e-7,0.00040692044,0.93595827],"study_design_scores_gemma":[0.0029962724,0.001924186,0.002568526,0.00808574,0.08324997,0.00053696294,0.00010351252,4.845235e-7,1.6405498e-7,7.6900966e-7,0.9000692,0.00046425365],"about_ca_topic_score_codex":0.00019685371,"about_ca_topic_score_gemma":7.634045e-7,"teacher_disagreement_score":0.935494,"about_ca_system_score_codex":0.00011545483,"about_ca_system_score_gemma":0.00035400054,"threshold_uncertainty_score":0.99977803},"labels":[],"label_agreement":null},{"id":"W2236378300","doi":"10.1007/s40256-015-0155-y","title":"Prolonged Clopidogrel Use is Associated with Improved Clinical Outcomes Following Drug-Eluting But Not Bare Metal Stent Implantation","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Victoria Heart Institute Foundation","funders":"","keywords":"Clopidogrel; Medicine; Hazard ratio; Drug-eluting stent; Stent; Myocardial infarction; Internal medicine; Confidence interval; Loading dose; Surgery; Cardiology; Percutaneous coronary intervention","score_opus":0.017007200535585007,"score_gpt":0.27220536490736424,"score_spread":0.2551981643717792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236378300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99241394,0.0023601174,0.0037261082,0.00049213984,0.0003877788,0.00047921692,0.000037467245,0.00006443619,0.000038791266],"genre_scores_gemma":[0.997123,0.00078089634,0.0007681422,0.0007931711,0.00030477208,0.000013585114,0.000011903324,0.000088165776,0.000116365845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995174,0.00093864877,0.0011632484,0.00049114256,0.001669052,0.0005639162],"domain_scores_gemma":[0.9968901,0.00059764535,0.0006746164,0.00072524353,0.00065352774,0.00045886452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030993812,0.0004270595,0.0024818697,0.00022400108,0.0001585684,0.00006399706,0.00024221714,0.00010962445,0.000013654546],"category_scores_gemma":[0.00075268286,0.0002481851,0.0076058474,0.00039058478,0.0003383068,0.0005119069,0.000054314198,0.00043943946,0.000008283415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026320086,0.00035322073,0.4181055,0.000036040718,0.13925906,0.0019567776,0.0008453445,0.000039749066,0.0011402214,0.000005297192,0.00010792937,0.43551883],"study_design_scores_gemma":[0.034421045,0.0029147228,0.9064684,0.0014554448,0.034506157,0.0020872902,0.0043157,0.000036639354,0.0066155433,0.000014701937,0.006002761,0.0011616024],"about_ca_topic_score_codex":0.00006508873,"about_ca_topic_score_gemma":0.000002529943,"teacher_disagreement_score":0.48836288,"about_ca_system_score_codex":0.00016836754,"about_ca_system_score_gemma":0.00039634737,"threshold_uncertainty_score":0.999997},"labels":[],"label_agreement":null},{"id":"W2306517593","doi":"10.2165/00129784-200202020-00007","title":"Micronized Fenofibrate","year":2002,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Fenofibrate; Medicine; Pharmacotherapy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.008870336507598806,"score_gpt":0.20431284820204446,"score_spread":0.19544251169444565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306517593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8791037,0.10188384,0.0049999715,0.0010367909,0.0006989624,0.00050734077,0.00000729732,0.000091030866,0.011671015],"genre_scores_gemma":[0.9862866,0.005583068,0.005737247,0.0005412958,0.0012831842,0.000008098021,0.0000029548462,0.000088931585,0.0004686121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667245,0.00036071858,0.00071432086,0.00032196695,0.0014069257,0.00052363606],"domain_scores_gemma":[0.9975544,0.00006024152,0.00040307402,0.0010094226,0.00049819076,0.00047462573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014979913,0.00032116022,0.002071641,0.00034888953,0.00009312965,0.000058365153,0.00028866567,0.00007541363,0.00021541391],"category_scores_gemma":[0.00014909374,0.00026602243,0.005142574,0.0006846037,0.00040724146,0.0002212972,0.00005280601,0.0004942701,0.00017444883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011923631,0.0001218426,0.00017344496,0.000043867458,0.01196112,0.0005112039,0.00063651724,0.0002370573,0.00017912946,0.000006573572,0.001999977,0.98401004],"study_design_scores_gemma":[0.008611522,0.0017016305,0.0061265677,0.00033507092,0.0068620634,0.0054786857,0.001605908,0.00014894112,0.0059683626,0.00004956953,0.9624644,0.0006472738],"about_ca_topic_score_codex":0.00052934303,"about_ca_topic_score_gemma":0.0000017481375,"teacher_disagreement_score":0.98336273,"about_ca_system_score_codex":0.00013360014,"about_ca_system_score_gemma":0.00010469309,"threshold_uncertainty_score":0.9999792},"labels":[],"label_agreement":null},{"id":"W2436268523","doi":"10.1007/s40256-016-0177-0","title":"Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"Canadian Institutes of Health Research; Pfizer Canada; Pfizer","keywords":"Eplerenone; Medicine; Context (archaeology); Heart failure; Cost effectiveness; Intensive care medicine; Spironolactone; Internal medicine; Cardiology","score_opus":0.009846662652232397,"score_gpt":0.23653199499962976,"score_spread":0.22668533234739738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436268523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936092,0.0029256775,0.0016643521,0.0011657617,0.000046351503,0.0005544909,0.000008031424,0.0000013434162,0.000024803321],"genre_scores_gemma":[0.99928546,0.0003386346,0.0002269698,0.000035311194,0.000055667024,0.000017666136,0.0000012482864,0.000016841774,0.000022175995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99875027,0.00016791621,0.00031839422,0.00010739118,0.0005114213,0.00014459307],"domain_scores_gemma":[0.9982303,0.0007800524,0.00021693528,0.00028851526,0.00038548623,0.00009875163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044092737,0.00012126539,0.0010124787,0.00009788095,0.00002267494,0.000002107376,0.000065115135,0.000021703423,0.0000044433255],"category_scores_gemma":[0.000053245178,0.00005376361,0.0005311951,0.00021082931,0.00017423778,0.000032681713,0.000004694329,0.000045102308,2.9678077e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012280534,0.00084104505,0.07480127,0.0004319901,0.028459314,0.0001560438,0.001697499,0.0061757388,0.010438234,0.00019811407,0.0005337645,0.86398643],"study_design_scores_gemma":[0.028818393,0.009126676,0.65034056,0.003023919,0.0048837666,0.0017487479,0.0019553828,0.00015133384,0.033831805,0.000011643555,0.26577187,0.00033590436],"about_ca_topic_score_codex":0.11867712,"about_ca_topic_score_gemma":0.015276275,"teacher_disagreement_score":0.86365056,"about_ca_system_score_codex":0.00027393838,"about_ca_system_score_gemma":0.00063302746,"threshold_uncertainty_score":0.8871917},"labels":[],"label_agreement":null},{"id":"W2531426511","doi":"10.1007/s40256-016-0196-x","title":"Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study","year":2016,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Mace; Internal medicine; Hazard ratio; Percutaneous coronary intervention; Acute coronary syndrome; Myocardial infarction; Clinical endpoint; Cardiology; Propensity score matching; Confidence interval; Clopidogrel; Randomized controlled trial","score_opus":0.005686644324525907,"score_gpt":0.24006108513601424,"score_spread":0.23437444081148834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531426511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915741,0.00088550075,0.006031108,0.00026483295,0.0001429446,0.0010545426,0.000009340083,0.000020943753,0.000016687842],"genre_scores_gemma":[0.9975609,0.0012446502,0.00081557006,0.00016233382,0.00009599635,0.000029556904,0.00000987981,0.00006277555,0.000018336363],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970322,0.00028834582,0.00064721995,0.0003244644,0.0013696019,0.00033813843],"domain_scores_gemma":[0.99846804,0.00018230508,0.00035741756,0.00036865514,0.0003835911,0.00024001897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010649238,0.0002647359,0.0011274096,0.00024939782,0.000061767496,0.000017217613,0.00018703156,0.00008808542,0.00002906228],"category_scores_gemma":[0.00007706184,0.00017348248,0.001126238,0.0002946335,0.00021234759,0.00022702392,0.000029598299,0.00026412655,0.0000024100561],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011043265,0.0019445441,0.15701683,0.00006487807,0.022020191,0.0047504827,0.0015046917,0.00019983306,0.002051615,0.0000041439034,0.000038498623,0.79936105],"study_design_scores_gemma":[0.087987006,0.061522316,0.7859502,0.004229732,0.0042684223,0.042296007,0.0061991084,0.00003831756,0.006117614,0.000042334497,0.00041692788,0.00093201536],"about_ca_topic_score_codex":0.000025085406,"about_ca_topic_score_gemma":0.0000043857463,"teacher_disagreement_score":0.798429,"about_ca_system_score_codex":0.00034261844,"about_ca_system_score_gemma":0.00033229997,"threshold_uncertainty_score":0.70744103},"labels":[],"label_agreement":null},{"id":"W2600702237","doi":"10.1007/s40256-017-0224-5","title":"A Systematic Review of Add-on Pharmacologic Therapy in the Treatment of Resistant Hypertension","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Native Mental Health Association of Canada; University of British Columbia","funders":"","keywords":"Medicine; Spironolactone; Adverse effect; Placebo; Randomized controlled trial; Blood pressure; Internal medicine; Meta-analysis; MEDLINE; Clinical trial; Doxazosin; CINAHL; Intensive care medicine; Heart failure; Alternative medicine","score_opus":0.09402899398896179,"score_gpt":0.36606181885738276,"score_spread":0.27203282486842095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600702237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090693145,0.99723893,0.0000010037593,0.00016711722,0.00012761114,0.0020521542,0.000011662323,0.000003396497,0.00030742236],"genre_scores_gemma":[0.0009173617,0.9981126,0.00004880864,0.00060538744,0.00017938782,0.00007938332,0.0000035717983,0.00003300655,0.000020484535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946759,0.0018110682,0.0018930107,0.00023447686,0.0011868482,0.00019870297],"domain_scores_gemma":[0.9941406,0.0007134172,0.00313998,0.0013297369,0.00060227263,0.00007398834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028208122,0.0004286372,0.013678697,0.00030645067,0.000055797937,0.000008170822,0.00042865475,0.000079950856,0.000007136543],"category_scores_gemma":[0.00024505492,0.00018058467,0.0067776428,0.00034104084,0.0002900817,0.000030100759,0.00002275487,0.00032464054,0.0000029333114],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014020033,0.00046042798,4.8865996e-7,0.35525036,0.029995719,0.0006259725,0.00028049698,4.823363e-7,0.0000014665184,0.0000013861518,0.0006813966,0.6125616],"study_design_scores_gemma":[0.0009516903,0.0027494535,0.000003958058,0.42716837,0.060470805,0.00089515024,0.00022341401,1.0177711e-7,0.0000056274775,7.3054383e-7,0.50743264,0.00009808743],"about_ca_topic_score_codex":0.000045130393,"about_ca_topic_score_gemma":2.9862085e-7,"teacher_disagreement_score":0.61246353,"about_ca_system_score_codex":0.000054779583,"about_ca_system_score_gemma":0.0003092744,"threshold_uncertainty_score":0.9350484},"labels":[],"label_agreement":null},{"id":"W2602040050","doi":"10.1007/s40256-017-0227-2","title":"The 100 Most Influential Papers in the Field of Thrombolytic Therapy: A Bibliometric Analysis","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Scopus; Medicine; Citation; Bibliometrics; MEDLINE; Library science; Family medicine; Political science; Computer science; Law","score_opus":0.027913649623673105,"score_gpt":0.3564253405306674,"score_spread":0.3285116909069943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602040050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002644264,0.99535084,0.00008893936,0.00010018187,0.00019400092,0.00065415225,0.000011530855,0.000007214004,0.0009489077],"genre_scores_gemma":[0.03305528,0.9661543,0.000029080142,0.00020637151,0.00044089364,0.000027652515,0.000010787914,0.000054684824,0.000021000204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937,0.00165101,0.0014974625,0.00036093267,0.002337491,0.00045306404],"domain_scores_gemma":[0.9936426,0.0013813648,0.0019764318,0.0024457118,0.00038177136,0.00017208465],"candidate_categories":["metaepi_narrow","metaepi_broad","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.0052270945,0.00053194625,0.006193895,0.016637484,0.00024334289,0.00015554373,0.0014934636,0.00018167649,0.00002852378],"category_scores_gemma":[0.00067749363,0.0002601116,0.020288438,0.04886294,0.0007419586,0.000111797184,0.00008041804,0.0009970005,0.0000042528914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001353956,0.00008840972,0.00012482374,0.00046710548,0.102050334,0.00024002691,0.00018125838,0.00005467488,1.5890299e-7,0.0000041048525,0.00009598829,0.8965577],"study_design_scores_gemma":[0.0012261822,0.00055361254,0.00190128,0.0017717179,0.056222465,0.0005627109,0.0005331707,0.000002005913,0.0000020958173,0.000004932864,0.9369663,0.0002535213],"about_ca_topic_score_codex":0.0002174063,"about_ca_topic_score_gemma":0.00000304368,"teacher_disagreement_score":0.93687034,"about_ca_system_score_codex":0.000083544306,"about_ca_system_score_gemma":0.00081568235,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2613851266","doi":"10.1007/s40256-017-0234-3","title":"66th Annual Scientific Sessions of the American College of Cardiology: 17–19 March 2017; Washington, DC, USA","year":2017,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa","keywords":"Medicine; Internal medicine; Pharmacotherapy; Cardiology; Medical education; Family medicine; Medical physics","score_opus":0.015226041359393906,"score_gpt":0.2860716492850451,"score_spread":0.27084560792565116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613851266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873345,0.0020441227,0.00027738695,0.0026475291,0.0006912498,0.00033839938,0.00015678475,0.000009080213,0.0065009287],"genre_scores_gemma":[0.9969228,0.00063596526,0.0007133303,0.00015588079,0.0003995327,0.0000046563355,0.000002571277,0.00003348889,0.0011317775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559486,0.00085006736,0.0009065083,0.0003563408,0.0018342483,0.0004579889],"domain_scores_gemma":[0.99425894,0.0005265275,0.0016955835,0.0021382973,0.0009807303,0.00039994344],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0037750693,0.0002853514,0.0034326934,0.00031053068,0.0004589341,0.00003529396,0.0009983247,0.00006826084,0.000016233802],"category_scores_gemma":[0.0010998546,0.00017874275,0.005786679,0.0006204293,0.0050492906,0.0001843179,0.00025179627,0.00054355874,0.0000047256235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025115486,0.00041959313,0.8036901,0.00031398606,0.03352463,0.0029032761,0.003346936,0.0026640086,0.0039104866,0.0012379221,0.03115699,0.11432053],"study_design_scores_gemma":[0.0018110257,0.0005236119,0.5577077,0.00022828976,0.0027873646,0.0025288062,0.0042776233,0.0000087013495,0.00082756695,0.000023153412,0.4290396,0.00023650005],"about_ca_topic_score_codex":0.00031001924,"about_ca_topic_score_gemma":0.0000043766618,"teacher_disagreement_score":0.3978826,"about_ca_system_score_codex":0.000100897385,"about_ca_system_score_gemma":0.0008008585,"threshold_uncertainty_score":0.9976584},"labels":[],"label_agreement":null},{"id":"W2618833385","doi":"10.1007/s40256-017-0229-0","title":"Thromboprophylaxis in Extracorporeal Circuits: Current Pharmacological Strategies and Future Directions","year":2017,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Current (fluid); Pharmacotherapy; Extracorporeal; MEDLINE; Medical physics; Internal medicine; Engineering","score_opus":0.04069440286404368,"score_gpt":0.3171915031520488,"score_spread":0.2764971002880051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618833385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044065525,0.9964329,0.00024088734,0.000005513814,0.001834782,0.00034669923,0.0000213516,0.000056854497,0.0006203546],"genre_scores_gemma":[0.0092787845,0.98883176,0.00009485075,0.0000033447425,0.0016650349,0.000034054698,0.000007658902,0.0000831799,0.0000013326139],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996912,0.00041859894,0.001191179,0.00037750506,0.0006847729,0.00041595043],"domain_scores_gemma":[0.9981564,0.00011649928,0.0007160719,0.00058338227,0.00011742214,0.00031018612],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011668055,0.000578847,0.0040430855,0.00045053777,0.00009200886,0.00021061838,0.00062810857,0.00020057373,0.00003286738],"category_scores_gemma":[0.000028073646,0.00045543924,0.0023797292,0.00041881454,0.0002835549,0.00048894406,0.00006458031,0.0016261076,0.000008206753],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000144448,0.000026077725,0.0000044548706,0.0021130359,0.0031015682,0.0002102725,0.0000955651,0.00009779828,2.6569612e-7,0.000033869197,0.000025314226,0.99429035],"study_design_scores_gemma":[0.00025027644,0.00009238,0.00009820715,0.0017878907,0.0030341514,0.00079089165,0.00031875802,0.000016887807,4.6928974e-7,0.00005901169,0.9930948,0.00045625516],"about_ca_topic_score_codex":0.000014852129,"about_ca_topic_score_gemma":0.000001947944,"teacher_disagreement_score":0.9938341,"about_ca_system_score_codex":0.000215292,"about_ca_system_score_gemma":0.00034520435,"threshold_uncertainty_score":0.9997897},"labels":[],"label_agreement":null},{"id":"W2799686913","doi":"10.1007/s40256-018-0273-4","title":"Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Clinical endpoint; Propensity score matching; Cardiology; Ejection fraction; Unstable angina; Revascularization; Heart failure; Acute coronary syndrome; Randomized controlled trial","score_opus":0.016333009582127574,"score_gpt":0.24719895070362996,"score_spread":0.23086594112150238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799686913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966539,0.00008188361,0.0005744904,0.0015936162,0.00003064854,0.00041929944,0.000024938508,0.000013814473,0.0006074035],"genre_scores_gemma":[0.998502,0.00006761686,0.0007303396,0.0002099057,0.0003120702,0.0000064476385,0.000028461056,0.000037649595,0.00010547195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952682,0.0006836148,0.00044785324,0.00031208014,0.002959752,0.00032845695],"domain_scores_gemma":[0.99464434,0.00025016966,0.0011462957,0.0008217445,0.0029483913,0.00018908216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014303643,0.00023624321,0.0013901677,0.00023820155,0.00015357228,0.00004848167,0.00025072828,0.000056650013,0.000013607354],"category_scores_gemma":[0.00019444695,0.00011952642,0.0007417643,0.0019705335,0.0006701804,0.00013174368,0.000047921978,0.0005194927,0.0000029537894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003547488,0.00011690476,0.911998,0.000009697621,0.079257585,0.0000614596,0.0005268346,0.00078430976,0.000025054374,6.951922e-7,0.00076658063,0.002905421],"study_design_scores_gemma":[0.005770405,0.004782202,0.95150006,0.00022202183,0.02747268,0.00006753077,0.001548065,0.00006197989,0.0032973886,9.3789737e-7,0.005029787,0.00024695738],"about_ca_topic_score_codex":0.002207929,"about_ca_topic_score_gemma":0.000056166973,"teacher_disagreement_score":0.051784903,"about_ca_system_score_codex":0.00026640564,"about_ca_system_score_gemma":0.00031083438,"threshold_uncertainty_score":0.4874146},"labels":[],"label_agreement":null},{"id":"W2889103054","doi":"10.1007/s40256-018-0298-8","title":"The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Intravascular ultrasound; Medicine; Interquartile range; Internal medicine; Cardiology; Atheroma; Apolipoprotein B; Cholesterol; Vulnerable plaque; Placebo; Rosuvastatin; Population; High-density lipoprotein; Gastroenterology; Pathology","score_opus":0.004287510522323123,"score_gpt":0.21273314523165138,"score_spread":0.20844563470932825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889103054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941535,0.00456018,0.00027966494,0.00018148104,0.00039075784,0.00034534297,0.00000981729,0.000003543621,0.00007572638],"genre_scores_gemma":[0.99801457,0.0004520543,0.00007711963,0.00009340438,0.0013005297,0.000007865444,0.000009274722,0.000022972656,0.00002223438],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977193,0.0009931882,0.00040004973,0.00021382,0.00050559104,0.00016805662],"domain_scores_gemma":[0.99865043,0.0002132184,0.00040537378,0.0004914082,0.0001495036,0.00009004137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009587253,0.00019287199,0.00045854866,0.00003345922,0.00017039769,0.000037028247,0.00029967728,0.000075078366,0.000003100585],"category_scores_gemma":[0.0002005111,0.00010260245,0.00057421776,0.00013160762,0.0009060058,0.000010363126,0.000066597255,0.00020928342,0.0000032119115],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0665244,0.00022495375,0.002472398,0.00003202276,0.012651726,0.000084256746,0.0012916364,0.00014017579,0.34569892,0.000046997102,0.005777475,0.565055],"study_design_scores_gemma":[0.04388982,0.035241395,0.014689773,0.00033906542,0.0014712147,0.00036098252,0.00093882886,0.0000632628,0.79484147,0.000081402715,0.10745268,0.0006301225],"about_ca_topic_score_codex":0.00003921194,"about_ca_topic_score_gemma":0.0000038491507,"teacher_disagreement_score":0.5644249,"about_ca_system_score_codex":0.000016794142,"about_ca_system_score_gemma":0.000067904126,"threshold_uncertainty_score":0.41840062},"labels":[],"label_agreement":null},{"id":"W2896677774","doi":"10.1007/s40256-018-0305-0","title":"Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: ATLANTIC-Morphine","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canada Research Chairs; Canadian Heart Research Centre; Southlake Regional Health Center; University of Toronto","funders":"AstraZeneca","keywords":"Medicine; Ticagrelor; Morphine; Percutaneous coronary intervention; Myocardial infarction; Cardiology; Internal medicine; Anesthesia","score_opus":0.006196942118179152,"score_gpt":0.23536688538845008,"score_spread":0.22916994327027093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896677774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903541,0.006079037,0.0023127075,0.00036663754,0.0003481914,0.00034390093,0.0000037277387,0.000018443116,0.0001732597],"genre_scores_gemma":[0.9935942,0.004681882,0.00063481514,0.00030571013,0.0006933249,0.000008117384,0.0000326793,0.000033930857,0.00001528634],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99751073,0.00036630066,0.0007568619,0.00030609893,0.0007897743,0.00027020494],"domain_scores_gemma":[0.99884754,0.00006235169,0.00029591742,0.00034031566,0.00029070082,0.00016318708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013474394,0.00024075207,0.0010355149,0.00052375696,0.000052165906,0.000031942403,0.0001004936,0.00007123515,0.000059547718],"category_scores_gemma":[0.000078769364,0.00021697891,0.0011246748,0.00051344396,0.0003250688,0.00033155558,0.000052793155,0.00040656087,0.000008831592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053955363,0.00045152826,0.08548024,0.00012577885,0.0063678883,0.0018720289,0.0011561913,0.0009165386,0.0016187056,0.000012722667,0.00013447135,0.89646834],"study_design_scores_gemma":[0.01270308,0.00450344,0.9153645,0.0012394754,0.0026720732,0.034409158,0.0038043193,0.00067695393,0.00032388052,0.000099671706,0.023621809,0.0005816622],"about_ca_topic_score_codex":0.00027014108,"about_ca_topic_score_gemma":0.0000101743735,"teacher_disagreement_score":0.8958867,"about_ca_system_score_codex":0.0003624035,"about_ca_system_score_gemma":0.00011081121,"threshold_uncertainty_score":0.8848143},"labels":[],"label_agreement":null},{"id":"W2901198550","doi":"10.1007/s40256-018-0309-9","title":"Trends in Hospital Visits for Generic and Brand-Name Warfarin Users in Québec, Canada: A Population-Based Time Series Analysis","year":2018,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; The Quebec Population Health Research Network; Université du Québec à Trois-Rivières; Université Laval; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Abbott Vascular; Institut National de Santé Publique du Québec","keywords":"Medicine; Warfarin; Population; Pharmacotherapy; Brand names; Series (stratigraphy); Advertising; Internal medicine; Atrial fibrillation; Business; Environmental health","score_opus":0.010188573071487614,"score_gpt":0.226260074158103,"score_spread":0.21607150108661538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901198550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283236,0.0031273228,0.0006746109,0.0027687673,0.000109722074,0.000084923755,0.0000868754,0.000003514309,0.00031187324],"genre_scores_gemma":[0.99852115,0.00020024095,0.0005695286,0.0004884534,0.00014489908,0.000006847262,0.000010847886,0.000019828774,0.000038203176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862576,0.00004163837,0.0007275429,0.00025290193,0.000066469045,0.00028572144],"domain_scores_gemma":[0.99911386,0.000069696485,0.0004023438,0.0002136105,0.00005158185,0.00014892966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072676723,0.00015350216,0.0010618143,0.0008711441,0.000045466517,0.000041846593,0.00016654296,0.000036237285,0.000059684473],"category_scores_gemma":[0.000059146194,0.00017096609,0.0006027531,0.0008794681,0.00009496031,0.0001796684,0.00002210361,0.00012147205,0.0000032376372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038089,0.0001633316,0.78553766,0.000032308064,0.008044674,0.00003659111,0.0015376352,0.056319848,0.0000039395,0.0009020212,0.001109826,0.1459313],"study_design_scores_gemma":[0.0033117593,0.0005171231,0.8253762,0.000019745492,0.00049832166,0.000013214608,0.00017374998,0.034025587,0.00003476087,0.00045701227,0.13493869,0.00063380884],"about_ca_topic_score_codex":0.42501554,"about_ca_topic_score_gemma":0.1643688,"teacher_disagreement_score":0.26064673,"about_ca_system_score_codex":0.0004222453,"about_ca_system_score_gemma":0.00020025161,"threshold_uncertainty_score":0.8508793},"labels":[],"label_agreement":null},{"id":"W2977710227","doi":"10.1007/s40256-019-00373-1","title":"Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries","year":2019,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Mace; Percutaneous coronary intervention; Internal medicine; Conventional PCI; Myocardial infarction; Acute coronary syndrome; Cardiology; Clinical endpoint; Randomized controlled trial","score_opus":0.006303911963001988,"score_gpt":0.19919777267439476,"score_spread":0.19289386071139278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977710227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897043,0.009591508,0.000048972914,0.00006537901,0.000015758105,0.0004907462,0.00001215706,0.0000038928283,0.0000672932],"genre_scores_gemma":[0.9944289,0.005397351,0.00008812074,0.000032993394,0.000015688334,0.0000015983029,0.000005057016,0.000017400333,0.00001294579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.0003177558,0.00050259684,0.0002473734,0.0007055082,0.00016841674],"domain_scores_gemma":[0.9983846,0.000102271406,0.0005053226,0.00051501713,0.00036801537,0.00012476342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007044666,0.00019580174,0.0017115789,0.0002573498,0.000040114188,0.000012385664,0.00009997719,0.00004957013,0.0000026257937],"category_scores_gemma":[0.00009865728,0.00011451064,0.0006656222,0.0010313969,0.0008329991,0.00010001772,0.000062542065,0.00020236101,1.12604674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038870745,0.00012102234,0.9004813,0.00013066565,0.023531662,0.000030886036,0.0006504423,0.00031337608,0.00007123364,0.000008403274,0.0000037161535,0.070770256],"study_design_scores_gemma":[0.008203124,0.0011057848,0.97547495,0.00056337484,0.012857464,0.00019104838,0.00051885523,0.000025718053,0.0004182959,0.0000022184595,0.000501769,0.00013736766],"about_ca_topic_score_codex":0.00013501025,"about_ca_topic_score_gemma":0.000005017202,"teacher_disagreement_score":0.07499372,"about_ca_system_score_codex":0.000030070594,"about_ca_system_score_gemma":0.00012073345,"threshold_uncertainty_score":0.46696085},"labels":[],"label_agreement":null},{"id":"W3067367675","doi":"10.1007/s40256-020-00428-8","title":"Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pharmacotherapy; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.021069936883145075,"score_gpt":0.34868845894899264,"score_spread":0.3276185220658476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3067367675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06216486,0.93616545,0.000104777246,0.000028245111,0.00021938578,0.0012218275,0.000057263187,0.000014144402,0.000024053863],"genre_scores_gemma":[0.04617555,0.9527583,0.00026410163,0.000104806735,0.0005119339,0.000026005258,0.000029871462,0.00012462684,0.000004782489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937441,0.0019034182,0.0017990066,0.00058110064,0.0015072449,0.00046515677],"domain_scores_gemma":[0.99613124,0.00022608992,0.0013504188,0.00095954974,0.00040984454,0.0009228619],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0015864738,0.00074373104,0.0093967505,0.00044320652,0.00003833067,0.000010580452,0.0004379687,0.00014036828,0.0000448403],"category_scores_gemma":[0.00007439304,0.00046398558,0.018785642,0.0009258818,0.0006156712,0.000120574296,0.000063407664,0.001280767,0.000015578104],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014941541,0.0010406539,0.028783603,0.0014094745,0.13427177,0.001452659,0.000091625945,0.0002696821,5.3391528e-8,2.958009e-7,0.000059193255,0.8311268],"study_design_scores_gemma":[0.018572003,0.005003376,0.048895333,0.010716078,0.108631834,0.0002693578,0.000020271902,0.0000054767975,0.0000019161605,0.0000024323206,0.80723387,0.0006480732],"about_ca_topic_score_codex":0.00005351971,"about_ca_topic_score_gemma":7.5071284e-8,"teacher_disagreement_score":0.8304787,"about_ca_system_score_codex":0.00057327835,"about_ca_system_score_gemma":0.001990355,"threshold_uncertainty_score":0.9997812},"labels":[],"label_agreement":null},{"id":"W3136802843","doi":"10.1007/s40256-021-00475-9","title":"Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries","year":2021,"lang":"en","type":"letter","venue":"American Journal of Cardiovascular Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Cross-sectional study; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Anticoagulant therapy; Pharmacotherapy; Environmental health; Virology; Internal medicine; Outbreak; Pathology; Infectious disease (medical specialty)","score_opus":0.027529928524689714,"score_gpt":0.34924095989345677,"score_spread":0.32171103136876705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136802843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674128,0.0069157663,0.0011092806,0.022550054,0.0007471831,0.00045990237,0.0006163002,0.000025494895,0.00016317947],"genre_scores_gemma":[0.8792098,0.0049566054,0.000075311,0.1130904,0.002387214,0.0000120267,0.0001302471,0.000058539965,0.00007986331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99388325,0.0006767421,0.0012135806,0.00054464623,0.0030539257,0.00062783516],"domain_scores_gemma":[0.9954277,0.00028659953,0.0016714435,0.0014023298,0.00091272325,0.000299167],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019745918,0.00053237827,0.003905489,0.0003170794,0.00021265914,0.00015210354,0.0005335577,0.00029702965,0.00010822444],"category_scores_gemma":[0.0003883952,0.0003398981,0.013239491,0.001624466,0.0011248023,0.00007757772,0.00019000114,0.001380432,0.000007964072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023042859,0.00023108892,0.7273851,0.0003152769,0.16112043,0.002194354,0.00061395083,0.025157552,0.0000033872243,0.0000061665273,0.0814637,0.0012785663],"study_design_scores_gemma":[0.001665306,0.0007089404,0.724179,0.00021106817,0.018572027,0.0028417883,0.00033032527,0.000010976224,0.0000041860544,0.000014598219,0.25114354,0.00031821057],"about_ca_topic_score_codex":0.0019113615,"about_ca_topic_score_gemma":0.000017755492,"teacher_disagreement_score":0.16967982,"about_ca_system_score_codex":0.0017474253,"about_ca_system_score_gemma":0.0018605758,"threshold_uncertainty_score":0.9999053},"labels":[],"label_agreement":null},{"id":"W3185695548","doi":"10.1007/s40256-021-00489-3","title":"The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery","year":2021,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Population Health Research Institute; Université de Montréal; Impact; Hamilton Health Sciences; Queen's University; McMaster University","funders":"","keywords":"Medicine; Dabigatran; Pharmacotherapy; Cardiac surgery; Cardiology; Surgery; Internal medicine; Atrial fibrillation; Warfarin","score_opus":0.0036022994011194296,"score_gpt":0.21216753228414847,"score_spread":0.20856523288302906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185695548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935487,0.0033627981,0.00014451401,0.0010269559,0.0002197918,0.00030345996,0.000018701116,0.000005700467,0.0013693897],"genre_scores_gemma":[0.9973903,0.0018503697,0.00021314333,0.0002373023,0.00021118172,0.000024353281,0.000010051322,0.0000323876,0.00003091306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973113,0.0004864123,0.00070285914,0.00020617111,0.0009805704,0.00031268003],"domain_scores_gemma":[0.9972472,0.00079463416,0.00029806682,0.0007172499,0.0007213118,0.00022154587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015123198,0.00019403233,0.0020207386,0.000163087,0.00005532619,0.000025912888,0.000120029064,0.000049093112,0.000007478401],"category_scores_gemma":[0.00019885467,0.00012277192,0.0037155324,0.0008032839,0.00039997965,0.00009885325,0.000031133764,0.00031739057,0.0000030429162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010803473,0.0001151212,0.76416326,0.00002068882,0.004504282,0.0001667212,0.0002340071,0.000052137355,0.00002172447,0.000021427235,0.00017571302,0.22944458],"study_design_scores_gemma":[0.0008509228,0.00017824113,0.9116614,0.00011194678,0.0012111202,0.00011977576,0.00048467852,4.38185e-7,0.0003098526,0.0000040020136,0.08492587,0.00014179207],"about_ca_topic_score_codex":0.000030554544,"about_ca_topic_score_gemma":0.0000011184364,"teacher_disagreement_score":0.2293028,"about_ca_system_score_codex":0.0000925718,"about_ca_system_score_gemma":0.000513456,"threshold_uncertainty_score":0.5006494},"labels":[],"label_agreement":null},{"id":"W32461932","doi":"10.2165/00129784-200101050-00001","title":"Antiatherosclerotic Effects of ACE Inhibitors","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Blood pressure; Internal medicine; ACE inhibitor; Endothelium; Aldosterone; Renin–angiotensin system; Heart failure; Clinical trial; Angiotensin-converting enzyme; Pharmacology","score_opus":0.018348154678419173,"score_gpt":0.2797059348951353,"score_spread":0.26135778021671613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W32461932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017319842,0.9983441,0.00009918365,0.0000572437,0.0005391587,0.00047754095,0.0000027236665,0.000013922036,0.00029292298],"genre_scores_gemma":[0.0009033862,0.99721044,0.0006410954,0.00012368136,0.00095322035,0.000007826776,0.000002152777,0.000088170986,0.000070030575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996628,0.0004980735,0.0011563684,0.0002751121,0.0011387486,0.00030372085],"domain_scores_gemma":[0.9967192,0.00039226885,0.0013927727,0.00073702633,0.0005386159,0.00022015773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085360464,0.00045972076,0.008980133,0.00044367954,0.00004578764,0.000011511332,0.00024645418,0.00014758311,0.0000070359756],"category_scores_gemma":[0.00018678597,0.00030695254,0.007545198,0.0008620119,0.00038324596,0.0000603624,0.000095597876,0.00071953895,0.000012990588],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019183715,0.000095909796,0.000009631835,0.009343178,0.036459308,0.00054957153,0.00017073467,0.0000025342767,0.0000020834545,0.0000012372109,0.0024091557,0.95093745],"study_design_scores_gemma":[0.00080778205,0.0006407524,0.000015448646,0.026773196,0.08003689,0.0025470187,0.0001580753,1.2275636e-7,0.000038960214,0.0000017118915,0.88875943,0.00022062009],"about_ca_topic_score_codex":0.000032737,"about_ca_topic_score_gemma":8.910429e-8,"teacher_disagreement_score":0.95071685,"about_ca_system_score_codex":0.000033733846,"about_ca_system_score_gemma":0.00035232492,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W4220824635","doi":"10.1007/s40256-022-00526-9","title":"Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Transthyretin; Placebo; Internal medicine; Cardiomyopathy; Heart failure; Clinical trial; Pathology","score_opus":0.0018581874210486509,"score_gpt":0.17583553539002972,"score_spread":0.17397734796898107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220824635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872342,0.00869186,0.0028510718,0.00009900808,0.00018193637,0.0006207699,0.00016516283,0.000020240062,0.00013576417],"genre_scores_gemma":[0.99795514,0.0007678107,0.00061058305,0.00012304599,0.00010010383,0.00011064273,0.00018614234,0.00012365854,0.000022864559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952911,0.0010520406,0.00071945385,0.00066820363,0.0017242357,0.000544982],"domain_scores_gemma":[0.9977351,0.000031537835,0.0005419822,0.0010041795,0.00047049596,0.00021672768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012617338,0.0004946642,0.0013854462,0.00034491625,0.00020244856,0.000030154497,0.0005100911,0.00008360701,0.000016650944],"category_scores_gemma":[0.000053739757,0.00041365126,0.0018513277,0.0010334781,0.00035007225,0.00004345921,0.0001330367,0.0004280426,0.0000024043334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002582086,0.0010376462,0.5768841,0.000046727127,0.03873722,0.0005042102,0.00339341,0.304379,0.00017393283,0.000013569119,0.00050121266,0.071746886],"study_design_scores_gemma":[0.04421977,0.021967966,0.77338445,0.00023260996,0.010176927,0.0010962568,0.020498242,0.00005028931,0.0048209755,0.000025771353,0.12028498,0.003241741],"about_ca_topic_score_codex":0.00021393252,"about_ca_topic_score_gemma":0.0000070262927,"teacher_disagreement_score":0.30432868,"about_ca_system_score_codex":0.00027578292,"about_ca_system_score_gemma":0.00029101322,"threshold_uncertainty_score":0.99983156},"labels":[],"label_agreement":null},{"id":"W4307717083","doi":"10.1007/s40256-022-00554-5","title":"Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry","year":2022,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Rivaroxaban; Acute coronary syndrome; Ticagrelor; Aspirin; Internal medicine; Antithrombotic; Cohort; Randomized controlled trial; Clopidogrel; Warfarin; Emergency medicine; Cardiology; Intensive care medicine; Myocardial infarction; Atrial fibrillation","score_opus":0.011633990064880684,"score_gpt":0.2883962855430063,"score_spread":0.2767622954781256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307717083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954256,0.0013830113,0.0006468451,0.0005681896,0.000087371074,0.0018048538,0.000053032763,0.0000073623687,0.000023741517],"genre_scores_gemma":[0.9992955,0.00027709664,0.00019511154,0.00007372995,0.00006860199,0.000017609045,0.000033403885,0.000019030964,0.00001995798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970314,0.0010429306,0.00068842695,0.0002736024,0.0007168299,0.0002467954],"domain_scores_gemma":[0.9982872,0.00038761742,0.0006335253,0.0004956788,0.00013177223,0.00006423273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035389247,0.00017864765,0.0010704598,0.00011855495,0.00017041732,0.00003108887,0.00018736452,0.000024941475,0.000012528453],"category_scores_gemma":[0.00010605813,0.000104854065,0.0006131849,0.0003702438,0.0002969884,0.00015583936,0.00012537328,0.0005038592,3.4617406e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024911745,0.00006293095,0.9739059,0.00005969715,0.0027396635,0.00003575063,0.00038468247,0.0013180692,2.9002814e-7,0.000020211228,0.000028651662,0.018952953],"study_design_scores_gemma":[0.01898935,0.0010966161,0.97482663,0.000058283415,0.002101758,0.00005536275,0.0019001962,0.0001341299,0.000001504612,0.00018439755,0.0005383508,0.00011339074],"about_ca_topic_score_codex":0.00024180539,"about_ca_topic_score_gemma":0.000015969246,"teacher_disagreement_score":0.018839562,"about_ca_system_score_codex":0.00018936525,"about_ca_system_score_gemma":0.00013522917,"threshold_uncertainty_score":0.42758247},"labels":[],"label_agreement":null},{"id":"W4353016809","doi":"10.1007/s40256-023-00576-7","title":"Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Veterans Affairs; Coronary artery disease; Internal medicine; Logistic regression; Odds ratio; Arterial disease; Cardiology; Vascular disease","score_opus":0.009363041760313886,"score_gpt":0.23838409481404813,"score_spread":0.22902105305373424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353016809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942368,0.002336614,0.0015327513,0.0006810838,0.00033386287,0.0006938536,0.00002438406,0.00007439712,0.00008621313],"genre_scores_gemma":[0.9958703,0.0018028198,0.0003103267,0.0005199025,0.0012173599,0.00007788052,0.00004786142,0.000097456425,0.000056071425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99539566,0.00060179434,0.0007798287,0.0004529915,0.002113663,0.0006560601],"domain_scores_gemma":[0.9972441,0.0000755318,0.0003047174,0.0010159239,0.000355434,0.0010042683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016667462,0.00038635853,0.0015676758,0.0005403166,0.00012696402,0.00009404166,0.00022228912,0.000051926774,0.000044353972],"category_scores_gemma":[0.00024852247,0.00027802543,0.0023196528,0.0013130623,0.00044632878,0.0004454765,0.00005365795,0.00048472758,0.000011394906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021974897,0.00079116935,0.67434055,0.0017327903,0.020445928,0.022576693,0.003624775,0.038691178,0.00005831168,0.000063945576,0.0005081158,0.21519163],"study_design_scores_gemma":[0.00814516,0.0008815666,0.97177565,0.0008217816,0.002743028,0.0004206909,0.0013072288,0.0004557022,0.000031435913,0.000027563949,0.012937495,0.0004526982],"about_ca_topic_score_codex":0.001128758,"about_ca_topic_score_gemma":0.000031633925,"teacher_disagreement_score":0.2974351,"about_ca_system_score_codex":0.0002814274,"about_ca_system_score_gemma":0.0010003505,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W4377093184","doi":"10.1007/s40256-023-00587-4","title":"Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Medicine; Ticagrelor; Perioperative; Cohort; Cost effectiveness; Antithrombotic; Surgery; Anesthesia; Clopidogrel; Internal medicine; Aspirin","score_opus":0.015448452788350098,"score_gpt":0.28272705070754967,"score_spread":0.26727859791919956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377093184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99559253,0.0024160878,0.00059913995,0.000023442417,0.00028504978,0.0009321702,0.000050156013,0.000032406013,0.00006901643],"genre_scores_gemma":[0.99754363,0.0019542903,0.000226592,0.000016777369,0.0001664761,0.000017659464,0.000009224376,0.0000618357,0.0000035290616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637073,0.0010136057,0.0006771313,0.00039554323,0.0011149285,0.0004280314],"domain_scores_gemma":[0.9974656,0.0008520984,0.0003930263,0.00047410975,0.00046215125,0.0003530301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037431347,0.00032919776,0.0024414142,0.00078174414,0.0000908056,0.00003229669,0.00012616182,0.000056720248,0.000001730937],"category_scores_gemma":[0.00047291518,0.00026343705,0.002990515,0.0014620253,0.00019736584,0.00017795298,0.00006115682,0.00033991388,0.0000059821796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007675145,0.0006882803,0.57406604,0.0010525121,0.054005463,0.00086222315,0.0045477618,0.100013256,0.00070906134,0.000025076895,0.00030418977,0.25605097],"study_design_scores_gemma":[0.0051734066,0.0014628472,0.9788453,0.003568655,0.0028303463,0.00028359657,0.005770022,0.00026867673,0.0013122525,0.0000020209045,0.000104366765,0.00037854008],"about_ca_topic_score_codex":0.00027669338,"about_ca_topic_score_gemma":5.9072227e-7,"teacher_disagreement_score":0.40477923,"about_ca_system_score_codex":0.0004329872,"about_ca_system_score_gemma":0.0004231641,"threshold_uncertainty_score":0.99998176},"labels":[],"label_agreement":null},{"id":"W4385442526","doi":"10.1007/s40256-023-00599-0","title":"Aficamten: A Breakthrough Therapy for Symptomatic Obstructive Hypertrophic Cardiomyopathy","year":2023,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Air Canada","funders":"","keywords":"Medicine; Pharmacotherapy; Hypertrophic cardiomyopathy; Internal medicine; Cardiology; Obstructive cardiomyopathy; Cardiomyopathy; Intensive care medicine; Heart failure","score_opus":0.03725592064992825,"score_gpt":0.31866510686583843,"score_spread":0.28140918621591016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385442526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058308145,0.9941607,0.001033548,0.000077704426,0.0013824312,0.0022278237,0.00011151198,0.0001051964,0.00031796537],"genre_scores_gemma":[0.0004832413,0.993806,0.0015288027,0.000093118855,0.0032464631,0.00036755923,0.000033715725,0.00033800807,0.00010308076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442333,0.0006887352,0.0018549663,0.00071512756,0.0015678214,0.0007500005],"domain_scores_gemma":[0.99471194,0.0008477929,0.0016425659,0.0013472252,0.0010838194,0.00036666196],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0022178658,0.0010038218,0.012463235,0.00083794387,0.00019605437,0.000065729524,0.0004894749,0.0002522404,0.0000039486063],"category_scores_gemma":[0.00041394154,0.00071817706,0.021991635,0.0016034496,0.00068230374,0.00013665055,0.0001333155,0.00089073565,0.000036474154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018437942,0.00005570372,0.000003896994,0.006028656,0.06308729,0.0005478422,0.00061786716,0.000018023782,4.419586e-7,0.000016245453,0.00059204723,0.9288476],"study_design_scores_gemma":[0.0023139487,0.0013795069,0.00004177297,0.012276685,0.03625181,0.00974753,0.001685496,0.0000015371154,0.000002139121,0.00005542781,0.93560684,0.00063730904],"about_ca_topic_score_codex":0.00003670956,"about_ca_topic_score_gemma":1.436433e-7,"teacher_disagreement_score":0.9350148,"about_ca_system_score_codex":0.00046920625,"about_ca_system_score_gemma":0.0010859666,"threshold_uncertainty_score":0.9995269},"labels":[],"label_agreement":null},{"id":"W4386100303","doi":"10.1007/s40256-023-00604-6","title":"Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universidade de Santiago de Compostela; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Instituto de Investigación Sanitaria de Santiago de Compostela; Fundación Instituto de Investigación Sanitaria de Santiago de Compostela","keywords":"Alirocumab; Evolocumab; Medicine; PCSK9; Internal medicine; Observational study; Cognition; Cognitive decline; Cholesterol; Lipoprotein; Dementia; LDL receptor; Psychiatry; Disease","score_opus":0.026190719571995584,"score_gpt":0.3075683294849671,"score_spread":0.2813776099129715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386100303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950032,0.00014255085,0.00014038007,0.0002702807,0.00019251643,0.0024625969,0.000004915892,0.00002896962,0.0017545832],"genre_scores_gemma":[0.99872327,0.000045563622,0.000025818345,0.00011791758,0.00047298011,0.0002202944,0.000014087303,0.00003473696,0.00034536156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946164,0.0010754438,0.00054476137,0.00036975896,0.0029809007,0.00041275125],"domain_scores_gemma":[0.997845,0.0003117759,0.00027238988,0.00031000556,0.0011147963,0.00014605514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042095645,0.00024796193,0.00082995923,0.000714987,0.00015529072,0.00007726832,0.00018809689,0.000021236356,0.000022777764],"category_scores_gemma":[0.00019365696,0.0001551525,0.000604816,0.0033041688,0.0002380563,0.00027449854,0.00006702983,0.0006642213,0.000020947537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004418141,0.0016162217,0.9367515,0.000011688772,0.008148112,0.0013456738,0.012598319,0.00005161603,0.000009801088,0.000004707645,0.0001663288,0.03487792],"study_design_scores_gemma":[0.011411239,0.011882104,0.76754284,0.00012668082,0.0023187404,0.000067218105,0.20616043,0.000010691809,0.000024692203,0.000019507039,0.0003060634,0.00012981112],"about_ca_topic_score_codex":0.00047937225,"about_ca_topic_score_gemma":0.00027904919,"teacher_disagreement_score":0.1935621,"about_ca_system_score_codex":0.00014537442,"about_ca_system_score_gemma":0.00045569238,"threshold_uncertainty_score":0.6326935},"labels":[],"label_agreement":null},{"id":"W4388766983","doi":"10.1007/s40256-023-00618-0","title":"The Use of Sodium-Glucose Cotransporter-2 Inhibitors in Coronary Revascularization: Where Are We Now? A Systematic Review","year":2023,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Coronary artery disease; Internal medicine; Percutaneous coronary intervention; Revascularization; Cardiology; Diabetes mellitus; Heart failure; Intensive care medicine; Myocardial infarction; Endocrinology","score_opus":0.0360141364876529,"score_gpt":0.28026528714409443,"score_spread":0.24425115065644154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388766983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016793872,0.9952841,0.00006960979,0.0004417367,0.00029537283,0.0038179995,0.000017674705,0.000024725912,0.000032029817],"genre_scores_gemma":[0.000024047353,0.99887776,0.000157123,0.00008681576,0.00015415157,0.00020071052,0.00004091985,0.00012783958,0.00033065103],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934233,0.0012084825,0.0029483696,0.0003729868,0.0016517158,0.0003951511],"domain_scores_gemma":[0.9942903,0.00047005896,0.0031428693,0.0014618086,0.00043685507,0.00019808898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002750494,0.0006040166,0.009001831,0.000493285,0.0000623744,0.000047547204,0.00045572082,0.00011445137,0.000006265366],"category_scores_gemma":[0.00017192373,0.0003575645,0.007484179,0.0017063901,0.00027788276,0.00016707681,0.000086087464,0.00056585006,0.00002664555],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017468501,0.00009353129,0.000029663237,0.63040406,0.024461186,0.0008207316,0.00007276176,0.000016995229,1.8010095e-8,0.0000049826554,0.0017273618,0.34235126],"study_design_scores_gemma":[0.00046091215,0.00016589533,0.000010803808,0.47618604,0.043185364,0.00019095285,0.0001653302,0.0000013369234,2.2352737e-7,0.0000013954544,0.47946745,0.00016428108],"about_ca_topic_score_codex":0.000026544974,"about_ca_topic_score_gemma":0.000009713172,"teacher_disagreement_score":0.4777401,"about_ca_system_score_codex":0.0003344657,"about_ca_system_score_gemma":0.0004037777,"threshold_uncertainty_score":0.99988765},"labels":[],"label_agreement":null},{"id":"W4390345179","doi":"10.1007/s40256-023-00620-6","title":"The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton General Hospital; Impact; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"Boston Scientific Corporation; Novo Nordisk; Sanofi; Bayer; AstraZeneca; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Rivaroxaban; Medicine; Aspirin; Discontinuation; Cost effectiveness; Stroke (engine); Coronary artery disease; Regimen; Population; Myocardial infarction; Internal medicine; Surgery; Anesthesia; Warfarin; Atrial fibrillation","score_opus":0.04505284589782036,"score_gpt":0.33500516003062203,"score_spread":0.28995231413280165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390345179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919138,0.0013639235,0.0010482647,0.0022533035,0.00024149765,0.0018747094,0.0000033007498,0.000025174435,0.0012760505],"genre_scores_gemma":[0.99905854,0.0002943691,0.00010129324,0.000070910544,0.0003922167,0.000017471577,0.000005455609,0.000027402428,0.000032336073],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99623173,0.0014166553,0.0005873651,0.0001980504,0.0012746108,0.0002915589],"domain_scores_gemma":[0.997128,0.0012672588,0.0005149929,0.00056371803,0.00043930052,0.000086704065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052981484,0.00020339827,0.0013484206,0.00030931894,0.000116133146,0.000041988464,0.0003332417,0.000028906137,0.0000028749819],"category_scores_gemma":[0.0002236973,0.00010716254,0.0011826127,0.001642175,0.00048111335,0.00009872994,0.000058501995,0.00032549174,0.0000074697496],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33350873,0.00036826948,0.1575527,0.0006764029,0.06380692,0.0023785995,0.028548755,0.24555676,0.0003868435,0.0065826112,0.0014337776,0.15919961],"study_design_scores_gemma":[0.1406838,0.0050051073,0.6968007,0.0008433266,0.0042970493,0.00042328873,0.070116445,0.0009175983,0.00040641337,0.00034538534,0.079648286,0.0005126208],"about_ca_topic_score_codex":0.00049734756,"about_ca_topic_score_gemma":0.00001694809,"teacher_disagreement_score":0.539248,"about_ca_system_score_codex":0.00023998678,"about_ca_system_score_gemma":0.00021598925,"threshold_uncertainty_score":0.43699613},"labels":[],"label_agreement":null},{"id":"W4402674819","doi":"10.1007/s40256-024-00682-0","title":"Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients with Heterozygous Familial Hypercholesterolemia: A Meta-analysis","year":2024,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Place Centre; University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Kexin; Proprotein convertase; Medicine; Subtilisin; Familial hypercholesterolemia; Meta-analysis; PCSK9; Pharmacotherapy; Pharmacology; Internal medicine; Oncology; Cholesterol; LDL receptor; Lipoprotein; Enzyme; Biochemistry","score_opus":0.026719737743964984,"score_gpt":0.29411280833595066,"score_spread":0.2673930705919857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402674819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033921096,0.9631618,0.00006699328,0.000026698708,0.00021960007,0.0024721324,0.00007230785,0.000021856229,0.000037489364],"genre_scores_gemma":[0.073256254,0.92518145,0.00057008705,0.00006303052,0.00046844242,0.00008600114,0.00010947207,0.00023086881,0.000034412642],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909145,0.0015601318,0.0026976198,0.00088099943,0.0033306475,0.00061610655],"domain_scores_gemma":[0.99469316,0.00013761743,0.0016209015,0.0020580254,0.0009993744,0.0004909049],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0033069085,0.0010072768,0.017153746,0.0021121318,0.000042148862,0.00005303288,0.00047746827,0.00032468553,0.00002110508],"category_scores_gemma":[0.00020848404,0.00059359544,0.027156014,0.003923651,0.0004624827,0.00014916391,0.00013240808,0.0018819598,0.000016770851],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045977806,0.00028951193,0.00010715633,0.005424594,0.46721298,0.0004956893,0.00021050307,0.000113267495,1.041529e-7,6.248683e-7,0.000023447563,0.52566236],"study_design_scores_gemma":[0.0031932616,0.0022309618,0.00038122947,0.003569138,0.8044482,0.00036528034,0.00012315827,0.0000017385784,0.000006864539,0.0000010097392,0.1851612,0.0005179911],"about_ca_topic_score_codex":0.00076616765,"about_ca_topic_score_gemma":0.00001095238,"teacher_disagreement_score":0.52514434,"about_ca_system_score_codex":0.00048443556,"about_ca_system_score_gemma":0.0016425905,"threshold_uncertainty_score":0.99965155},"labels":[],"label_agreement":null},{"id":"W4408622288","doi":"10.1007/s40256-025-00727-y","title":"Cardiovascular Safety Profile of Semaglutide and Variations by Sex, Race, and Kidney Function: A Systematic Review and Meta-analysis","year":2025,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Semaglutide; Meta-analysis; Pharmacotherapy; Renal function; Internal medicine; Endocrinology; Diabetes mellitus; Type 2 diabetes","score_opus":0.011901759979135762,"score_gpt":0.26119906985954283,"score_spread":0.24929730988040708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408622288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.181432e-7,0.9933238,0.0030719726,0.00022543504,0.00003745952,0.0027384518,0.00016372617,0.000013134387,0.00042508825],"genre_scores_gemma":[0.000024287916,0.9968519,0.0011425704,0.00036368603,0.000036626647,0.00020988124,0.00008962018,0.00003895693,0.0012424673],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952466,0.0012456048,0.0017496704,0.0005276783,0.0009805583,0.0002498939],"domain_scores_gemma":[0.9963905,0.00030481032,0.0014286205,0.001153148,0.00036780082,0.00035509263],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0035328155,0.00059900054,0.02103661,0.00071530027,0.00008589046,0.000043591153,0.00015176498,0.000095824624,0.000034993434],"category_scores_gemma":[0.00029899448,0.00039074456,0.012830608,0.0015500793,0.00023280631,0.000096977245,0.00014134776,0.00030447458,0.0000011666995],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043347573,0.000031029682,0.000001849968,0.33500925,0.5982953,0.00001917629,0.000036777772,0.0000030452093,9.8984465e-9,0.000010094703,0.00052171975,0.066067465],"study_design_scores_gemma":[0.000370823,0.00013966221,0.0000021538358,0.018106472,0.6353395,0.00012808849,0.000050472154,0.00000217245,1.2838167e-7,0.0000014551993,0.34570003,0.00015907416],"about_ca_topic_score_codex":0.000037948816,"about_ca_topic_score_gemma":1.5930226e-7,"teacher_disagreement_score":0.34517828,"about_ca_system_score_codex":0.00009742051,"about_ca_system_score_gemma":0.00028665256,"threshold_uncertainty_score":0.99985445},"labels":[],"label_agreement":null},{"id":"W4411698506","doi":"10.1007/s40256-025-00740-1","title":"A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers","year":2025,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Drug; Pharmacotherapy; Pharmacokinetics; Pharmacology; Rosuvastatin Calcium; Drug interaction; Drug-drug interaction; Internal medicine","score_opus":0.0394081592109647,"score_gpt":0.37937407008664825,"score_spread":0.33996591087568356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411698506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678696,0.008900757,0.00043165713,0.0016208217,0.00047595124,0.0015779139,0.000007660429,0.000015098713,0.00018317702],"genre_scores_gemma":[0.9959569,0.0019501863,0.000616214,0.0010926473,0.00022049941,0.00006620632,0.000001313493,0.00003537143,0.0000606537],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9932232,0.0026484202,0.0014077169,0.00038054917,0.0019324297,0.00040769673],"domain_scores_gemma":[0.9969114,0.0007503834,0.00076379953,0.00075649685,0.0006553831,0.00016251145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00897794,0.0003192767,0.0017074601,0.0006294619,0.00012662497,0.000035078952,0.00033021334,0.0000305821,0.000038888636],"category_scores_gemma":[0.0004833909,0.00019640784,0.0015111759,0.0015097377,0.00040986983,0.00013421179,0.00004038994,0.0008599286,0.0000025885768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010854106,0.00090196007,0.00543427,0.00023169952,0.010381292,0.00021404565,0.015504631,0.008490006,0.001627974,0.000015512973,0.00019096397,0.9461535],"study_design_scores_gemma":[0.090883136,0.06469784,0.350007,0.007344922,0.009588761,0.002449104,0.43148062,0.0026089423,0.020819157,0.00020291006,0.018213581,0.0017040448],"about_ca_topic_score_codex":0.0033039586,"about_ca_topic_score_gemma":0.000050776507,"teacher_disagreement_score":0.9444495,"about_ca_system_score_codex":0.00033778316,"about_ca_system_score_gemma":0.0015766363,"threshold_uncertainty_score":0.8009279},"labels":[],"label_agreement":null},{"id":"W4416276341","doi":"10.1007/s40256-025-00777-2","title":"Cardiovascular Pharmacotherapy and Glucose Metabolism: The Good, the Bad and the Unsightly","year":2025,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Insulin resistance; Pharmacotherapy; Type 2 Diabetes Mellitus; Diabetes mellitus; Disease; Narrative review; Type 2 diabetes; Adverse effect; Thiazide","score_opus":0.0038628162712345195,"score_gpt":0.22686060347112072,"score_spread":0.2229977871998862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276341","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32872462,0.6453191,0.0017178123,0.016600024,0.00048272606,0.0011374031,0.0000024511257,0.000023186256,0.005992647],"genre_scores_gemma":[0.9176066,0.077868745,0.0002171687,0.0034970045,0.00036742393,0.000039481376,8.48567e-7,0.00002605721,0.00037666946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764574,0.0007163725,0.00036956335,0.0002273391,0.0007731123,0.0002679003],"domain_scores_gemma":[0.9984164,0.0003143174,0.00017856163,0.0008142501,0.00017536517,0.000101089165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00314096,0.00024943755,0.0011364288,0.00012430719,0.00028143282,0.00010761398,0.00029181648,0.000025647885,0.0000069480857],"category_scores_gemma":[0.000049689857,0.00010027953,0.0019773843,0.00050802284,0.0012286607,0.000101639656,0.00011140598,0.00033738514,0.0000021918954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004276676,0.000050805967,0.00033017722,0.000029801504,0.074328125,0.000059206446,0.0015881902,0.00021750714,0.000042588465,0.0024754705,0.0012702991,0.91918015],"study_design_scores_gemma":[0.009395143,0.00014151561,0.00553571,0.000078039724,0.02334821,0.00019961635,0.003070199,0.00008641772,0.00070905226,0.0003432331,0.95695716,0.00013570346],"about_ca_topic_score_codex":0.00014346196,"about_ca_topic_score_gemma":8.505267e-7,"teacher_disagreement_score":0.95568687,"about_ca_system_score_codex":0.000036732567,"about_ca_system_score_gemma":0.000085110456,"threshold_uncertainty_score":0.45270517},"labels":[],"label_agreement":null},{"id":"W68433167","doi":"10.2165/00129784-200101020-00002","title":"Patients With Atherosclerotic Vascular Disease","year":2001,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Homocysteine; Medicine; Internal medicine; Vascular disease; B vitamins; Fibrinogen; Risk factor; Vitamin B12; Endocrinology; Cyanocobalamin; Endothelial dysfunction; Pyridoxine; Stroke (engine); Niacin","score_opus":0.016297677009114234,"score_gpt":0.28324268598161384,"score_spread":0.2669450089724996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W68433167","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018787243,0.9965372,0.00023753103,0.0000247095,0.00011793874,0.0008933235,0.000015790829,0.000018170178,0.00027657818],"genre_scores_gemma":[0.000562703,0.998093,0.00032428777,0.00008475608,0.0005536399,0.00002200235,0.0000474167,0.00017320595,0.00013895491],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99476075,0.0005738507,0.00092482555,0.00044068048,0.0027308867,0.00056900067],"domain_scores_gemma":[0.9961064,0.000104981664,0.0007236913,0.0012791794,0.00084549707,0.0009402431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009863352,0.0005865195,0.0048623676,0.0006403377,0.00007622151,0.000054730794,0.00044755542,0.000092997056,0.00005868216],"category_scores_gemma":[0.00013918601,0.0003559013,0.0068068034,0.0013893949,0.0004277188,0.00014035348,0.00008287387,0.0010535708,0.00007784835],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011926344,0.00024798414,0.00031789634,0.0028932237,0.019551259,0.00068950665,0.000038342347,0.000016986496,9.105178e-9,8.497761e-7,0.00016386167,0.9759608],"study_design_scores_gemma":[0.0018703877,0.0012043542,0.0010240705,0.012320297,0.02439453,0.00029301626,0.00005029036,0.000001038755,7.4301376e-8,0.0000012403062,0.95847213,0.00036855074],"about_ca_topic_score_codex":0.00003339962,"about_ca_topic_score_gemma":1.3083351e-7,"teacher_disagreement_score":0.97559226,"about_ca_system_score_codex":0.000330556,"about_ca_system_score_gemma":0.0012274841,"threshold_uncertainty_score":0.9998893},"labels":[],"label_agreement":null},{"id":"W79675979","doi":"10.2165/00129784-200606050-00006","title":"The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study)","year":2006,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo","keywords":"Olmesartan; Medicine; Internal medicine; Angiotensin II; Cardiology; Angiotensin II receptor type 1; Vascular resistance; Blockade; Atenolol; Essential hypertension; Urology; Blood pressure; Endocrinology; Receptor","score_opus":0.004372642364146629,"score_gpt":0.2060415327259775,"score_spread":0.20166889036183086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79675979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94992363,0.043709677,0.00057397474,0.003937797,0.00013404913,0.0011165423,0.0000011258848,0.000018509352,0.00058469595],"genre_scores_gemma":[0.9981707,0.0004166828,0.00053902954,0.0002915189,0.00041581187,0.000019157318,2.1375578e-7,0.000034859953,0.00011202496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972354,0.00045960015,0.00049515837,0.00023007722,0.0013101122,0.00026963587],"domain_scores_gemma":[0.9973241,0.000450878,0.00049882,0.0007197547,0.0009322455,0.0000741721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013372878,0.00023160907,0.0012795768,0.00010594592,0.0004445658,0.000018453162,0.0002061391,0.000031903754,3.87193e-7],"category_scores_gemma":[0.00015002815,0.00010931254,0.0007971337,0.00048411122,0.00049467385,0.00004813203,0.00005384661,0.00047806837,8.622278e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032702897,0.006474022,0.008354765,0.0007871178,0.27173996,0.0054598483,0.048903815,0.030512989,0.023639906,0.00040586112,0.039111942,0.53190684],"study_design_scores_gemma":[0.038589258,0.033532895,0.1686708,0.007180746,0.09725036,0.00366403,0.06083308,0.0002563452,0.10895522,0.000783931,0.4782857,0.0019976278],"about_ca_topic_score_codex":0.00015983022,"about_ca_topic_score_gemma":0.00001713207,"teacher_disagreement_score":0.52990925,"about_ca_system_score_codex":0.00002890229,"about_ca_system_score_gemma":0.00012420665,"threshold_uncertainty_score":0.44576362},"labels":[],"label_agreement":null},{"id":"W940111687","doi":"10.2165/00129784-200404040-00001","title":"Carnitine Palmitoyltransferase-I, a New Target for the Treatment of Heart Failure","year":2004,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Heart failure; Carnitine; Beta oxidation; Medicine; Fatty acid metabolism; Diabetic cardiomyopathy; Internal medicine; Diabetes mellitus; Fatty acid; Heart disease; Metabolism; Cardiomyopathy; Endocrinology; Pharmacology; Cardiology; Biochemistry; Chemistry","score_opus":0.018183394067316703,"score_gpt":0.2860817668543604,"score_spread":0.26789837278704365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W940111687","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006276994,0.98631454,0.010717082,0.0003244394,0.00072275655,0.0017342806,0.00007391945,0.000021366468,0.00002882954],"genre_scores_gemma":[0.00030347757,0.9934726,0.003616506,0.00003936027,0.0021863275,0.000054558255,0.000054922464,0.00014251367,0.00012978101],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961955,0.0003684182,0.0013749413,0.00039432727,0.0012434298,0.00042338434],"domain_scores_gemma":[0.9966647,0.0004366499,0.00074852764,0.0011726012,0.00053325976,0.000444257],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0008892329,0.0006894496,0.0071951766,0.00043651438,0.00010592637,0.000028913713,0.000269079,0.00019526885,0.00004514374],"category_scores_gemma":[0.00009555943,0.0003724149,0.029483493,0.0007696774,0.00034655357,0.00005558304,0.000013722371,0.0004953474,0.000008382067],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013739402,0.00015009269,0.000015447928,0.0023215315,0.05118992,0.000055536555,0.00035207134,0.00043359032,5.69738e-7,0.0000049518567,0.0009068528,0.944432],"study_design_scores_gemma":[0.0035010856,0.002964238,0.000014020816,0.004541931,0.05105657,0.0032534816,0.0005568931,7.29e-7,0.00003185537,0.0000049921996,0.9337709,0.0003032982],"about_ca_topic_score_codex":0.0003659545,"about_ca_topic_score_gemma":0.0000023285045,"teacher_disagreement_score":0.94412875,"about_ca_system_score_codex":0.00051867793,"about_ca_system_score_gemma":0.0027553977,"threshold_uncertainty_score":0.9998728},"labels":[],"label_agreement":null}]}